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Cell migration is an orchestrated and highly coordinated multi-step process that is central 
to the development and maintenance of multicellular organisms. Dysregulated migration 
however, is associated with pathological states such as tumor formation and metastasis; thus a 
clear understanding of the molecular mechanisms that drive this process is critical to the 
development of counteracting therapeutics.  
Cell migration and adhesion-dependent cell spreading share a number of features. For example, 
both processes rely on the activation of mechanisms for the coordinated spatial and temporal 
assembly/disassembly of focal adhesions, as well as mechanisms controlling actin 
rearrangements and directed vesicular trafficking. Actin remodeling and vesicular trafficking 
events are in turn, implicated functions of a variety of small GTPases of the Ras superfamily, 
which include the Rho and Arf subfamilies. Thus towards efforts of further characterizing the 
molecular pathways that drive cell spreading, I pursued aims to examine the role of a specific 
member of the Arf subfamily Arf6, in this process. In contrast to other studies which have 
primarily used constitutively active or dominant negative mutants of Arf6 to study its cellular 
function, we employed mouse genetics. In this system, mouse embryonic fibroblasts (MEFs) 
were derived and immortalized from mice genetically manipulated for the acute deletion of Arf6 
using a tamoxifen inducible Cre/loxP recombination system. Acute deletion of Arf6 in these 
MEFs resulted in a kinetic delay in transferrin recycling as well as in cell spreading. The 





membranes to the plasma membrane. Cholera toxin-B labels the ganglioside GM1, which is 
enriched in lipid rafts. These specialized membrane domains are thought to serve as signaling 
hubs bearing many proteins that in turn, mediate trafficking steps required for cell 
spreading/migration. I further report that the trafficking of these specialized membranes to the 
plasma membrane involves the retromer complex, a coat-like multi-protein complex primarily 
known for mediating retrograde transport from endosomes to the trans-Golgi network. 
Altogether, my studies have confirmed genetically, an involvement of Arf6 in cell spreading and 
raft trafficking, and established a link between these membrane microdomains and the retromer 
complex.  
In separate studies, I have also investigated the role of phospholipase D2 (PLD2) in 
endocytic trafficking and found that similarly derived cultures exhibit alterations in the 
expression levels of various trafficking related proteins as well as defects in transferrin and 
epidermal growth factor receptor trafficking. These results suggest a role for PLD2 and possibly 
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1.1 Introduction to cell migration and integrin trafficking 
 
Cell migration underlies many important physiological processes including cellular organization 
(Locascio and Nieto, 2001) and oogenesis (Rorth, 2002) during development, and tissue 
regeneration during repair (Friedl and Gilmour, 2009). Dysregulated migration however, may 
lead to the advancement of pathological states such as arthrosclerosis (Kraemer, 2000) and 
metastasis during cancer progression (Ozerlat, 2009). The molecular processes that underlie 
motile functions in cells involve complex biochemical reactions and cellular events, and must be 
highly coordinated at a cellular scale if motility is to be functional and successful. Given the 
importance of cell migration and motility to physiology, the elucidation of the molecular 
mechanisms that underlie these processes has been of keen interest.  
1.1.1 Integrin and focal adhesion mobilization in migrating cells  
 
The temporal and spatial establishment of integrin-based transient attachment sites to the 
extracellular matrix is a key aspect of directional migration in adherent cells. This attachment is 
mediated by integrin clusters that form plaques known as focal adhesions which serve as traction 
points for cells that mediate molecular links between the extracellular matrix and the 
cytoskeleton (Broussard et al., 2008; Webb et al., 2002). Myosin motor-generated force 
contractions at actin stress-fiber linked focal adhesions is thought to propel the cell body forward 
and initiate the subsequent formation of new adhesion complexes at the base of membrane 
protrusions at the leading cell edge (Chao and Kunz, 2009; Lecuit et al., 2011; Parsons et al., 





cell edge and at other regions on the ventral cell surface, is however equally important if 
migration is to proceed as it allows for cell retraction or detachment at the trailing edge 
(Henriksen et al., 1994; Webb et al., 2004). This assembly and disassembly of focal adhesions 
attachment sites is thought to be tightly coupled to the exo-endocytic cycles of integrins.  
Twenty four distinct non-covalently associated transmembrane heterodimer pairs of α- 
and β-subunits comprise the integrin family of membrane receptors, which are a group of 
proteins that mediate cell attachment to the extracellular matrix (Caswell et al., 2009). Each 
subunit is composed of an extracellular domain, a membrane-anchoring domain and a typically 
short cytoplasmic domain which provides a molecular receptor for attachment to the 
cytoskeleton largely through a variety of adaptor proteins (Hynes, 2002). In addition to 
mediating cell attachment, integrins also serve as transducers that convey bi-directional signals 
across the cell membrane towards various functional ends including cell migration, proliferation, 
apoptosis and phagocytosis (Bretscher, 1989; Caswell and Norman, 2006; Coppolino and 
Dedhar, 2000; Hynes, 2002; Qin et al., 2004). In the late 1980’s and early 1990’s it became 
evident from biochemical experiments pioneered by Mark Bretscher, that some integrin 
heterodimers were transient molecules at the plasma membrane being constantly endocytosed 
into internal compartments and recycled back to the plasma membrane (Bretscher, 1989, 1992). 
Today, it is firmly established that the trafficking of integrins in adherent cells is a highly 
efficient process required for various cellular events, such as cell spreading and migration and is 
implicated in diseases such as cancer and cell invasion (Margadant et al., 2011).  These events 
entail the delivery of newly synthesized integrin molecules via the biosynthetic-secretory 
pathway to the plasma membrane and the subsequent retrieval and restoration during endocytosis 





compartments for degradation, a process that is important for the removal and of damaged or 
mis-folded integrins from the recycling pathway (Caswell and Norman, 2006).  
1.1.2 Integrin endocytosis 
 
In adherent cells the integrin trafficking cycle is a rapid and selective process (it is postulated 
that the entire surface pool of integrins transits the endocytic system once every 30min (Fabbri et 
al., 1999; Roberts et al., 2001; Roberts et al., 2004; Strachan and Condic, 2004), with  some 
heterodimers being more mobile and more rapidly endocytosed than others (Bretscher, 1992). 
Integrin endocytosis can occur through both clathrin-dependent  and clathrin-independent 
mechanisms, and a given integrin heterodimer may in addition be internalized through both 
mechanisms as is the case with α5β1 and αvβ3 integrins which are both endocytosed through 
clathrin and caveolae-dependent mechanisms (Mineo et al., 1998; Strachan and Condic, 2004; 
Wary et al., 1996; Ylanne et al., 1995). The cytoplasmic tail of many integrin β-subunits contain 
a canonical clathrin sorting motif (NXXY/NPXY) known to recruit clathrin adaptors that include 
Dab-2 (disabled), and Numb, which both contain phosphotyrosine binding domains, and 
contribute to their internalization through clathrin mediated mechanisms (Calderwood et al., 
2003). Numb for example was found to localize in clathrin coated structures near focal adhesions 
at the leading edge of cells migrating towards integrin substrates (Nishimura and Kaibuchi, 
2007). Similarly, depletion of DAB2 was found to inhibit focal adhesion disassembly leading to 
a decreased rate of migration (Ezratty et al., 2009).  Other adaptors such as HAX1 (HCls1 
associated protein) (Ramsay et al., 2007) and ARH (autosomal recessive hypercholesterolemia 
(Ezratty et al., 2009) have also been implicated in clathrin mediated integrin endocytosis during 





As mentioned above, the internalization route of integrins may also be via clathrin-
independent mechanisms, but these pathways are relatively poorly defined. Furthermore, some 
integrins may be triggered for internalization through clathrin-independent endocytic pathways, 
as is the case with α5β1 integrins which typically is internalized into clathrin coated structures 
(in an NXXY-dependent manner), but has been reported to be routed towards clathrin 
independent endocytosis (in the same cell type) when Rab21 is expressed. This Rab21 (a poorly 
characterized member of the Rab family of small GTPases) has regulatory functions in early 
endosomes (Simpson et al., 2004) and has been linked to the endosomal trafficking of β1 
integrins (Pellinen et al., 2006). 
Protein kinase Cα  involvement in the endocytosis of β1 integrins  has also led to 
suggestions that this protein may facilitate the internalization through caveolar endocytosis 
(which is dynamin dependent (Nabi and Le, 2003))  as this kinase has known to facilitate 
endocytosis through this pathway (Mineo et al., 1998; Ng et al., 1999)(Nakashima, 2002; Sharma 
et al., 2004; Upla et al., 2004).  It has moreover become clear that certain integrins partition into 
cholesterol sensitive detergent-resistant membrane microdomains (DRMMs) that contain 
caveolin, as has been shown for αLβ2 integrin (Fabbri et al., 2005) which is proposed to remain 
associated with DRMM’s throughout its exo-endocytic journey.  
Focal adhesion disassembly requires integrin endocytosis , and following endocytosis 
(either through clathrin dependent or independent pathways), endocytosed  integrins are routed 
towards early sorting endosomes which are distributed largely in the peripheral cytoplasm, and 
towards the leading edge of migrating cells (Chao and Kunz, 2009; Ezratty et al., 2009; Pierini et 






1.1.3 Sorting from early endosomes  
 
At the sorting endosomes, key decisions (involving protein kinases and GTPases of the Rab and 
Arf families) are made regarding the fate of internalized receptors as to whether they routed to 
multivesicular bodies, late endosomes and lysosomes for degradation, or whether they will be 
recycled to the plasma membrane. Lysosomal routing may be activated for the removal of 
damaged, misfolded or cross-linked integrins from the trafficking pathway, which may otherwise 
disrupt cell migration. This decision for degradation is thought to be initiated by the 
ubiquitination of the receptor, and may serve additional roles to prevent endosomal accumulation 
of ligand-bound integrins (Lobert et al., 2010).  Generally however, integrins are mostly 
efficiently recycled to the plasma membrane. Recycling may occur via two temporally and  
spatially distinct mechanisms, which include a Rab-4 dependent fast recycling route occurring 
directly from sorting endosomes, or a slower recycling route where cargo is moved to a peri-
nuclear recycling compartment before moving to the plasma membrane in a Rab11 and/or Arf6 
dependent manner (Caswell and Norman, 2008; Caswell and Norman, 2006; Jones et al., 2006; 
Pellinen and Ivaska, 2006).   
Fast recycling as indicated relies on the small GTPase Rab4 and on PKD1 (protein kinase 
D1) the latter of which has been shown to directly bind β3 integrin and direct its transport during 
cell migration, as expression of a β3 mutant that does not bind to PKD1 results in a failure of 
αvβ3 integrin to concentrate at the leading edge of fibroblasts (Woods et al., 2004). 
Recycling receptors may alternatively be sorted through the perinuclear recycling 
compartment (or recycling endosomes), to be returned to the plasma  membrane through a 
Rab11- dependent process. It is now established that a range of integrin receptors utilize this 





in turn direct integrin containing vesicles to the plasma membrane  by binding to myosin Vb, via 
its effector protein FIP2(rab11-family interacting protein 2), which has be implicated in the 
trafficking of other receptors, such as the transferrin receptor and the epidermal growth factor 
receptors to the plasma membrane (Fan et al., 2004; Hales et al., 2002). Rab11 has also been 
shown to act in conjunction with the small GTPase Arf6 to regulate the exit of β1-integrin from 
this perinuclear recycling compartment (Powelka et al., 2004). The FIPs have been also been 
shown to bind Arf’s and are thus thought to be dual effectors for these two families of GTPases 
(Hickson et al., 2003). Other specific signaling pathways may converge on these proteins to 
impose selectivity on Rab11-dependent transport of integrins to the plasma membrane. These 
include PKB/AKT-mediated phosphorylation of GSK-3β which in turn may alter microtubular 
stability (Yoon et al., 2005) and direct plasma membrane transport by phosphorylation of kinesin 
light chain (Morfini et al., 2002).  PKCε, similarly to PKB/AKT, has also been implicated in the 
trafficking of β1 integrin (Ivaska et al., 2002). However the specific mechanism by which these 
kinases as well as their effectors promote integrin transport and tethering to motor proteins and 
the cytoskeleton remains to be elucidated. 
After leaving endosomes, integrins are finally transported to the cell surface where, in 
conjunction with Golgi-derived vesicular pools from the secretory pathway, they impact cell 
migration. This process involves mechanisms that direct their polarized placement in sites at the 
advancing lamellipodium along microtubules in migrating cells (Schmoranzer et al., 2003). 
 
1.2 CELL SPREADING 






It has been widely assumed that cell migration and cell spreading are related processes as the 
component parts of the machinery that function towards both ends, are largely overlapping.  For 
example, migrating cells must balance the assembly and disassembly of new cell-matrix contacts 
at their leading edges, with the coordinated disassembly of other contacts at the trailing cell edge; 
a process that relies on the controlled spatial and temporal regulation of focal adhesions (Nagano 
et al., 2012). Similarly in part, focal adhesion assembly is also an integral part of cell spreading 
as this is required to accommodate an advancing cell edge, as cells begin to assume their final 
spread area (Partridge and Marcantonio, 2006). During spreading, cell attachment to a matrix 
precedes a pulse of cargo-containing exocytic vesicles in unidirectional flow from internal 
compartments to the plasma membrane, resulting in a net increase in the surface area of the 
plasma membrane (Balasubramanian et al., 2007). The synchronous nature of this vesicular flow 
to the cell edge greatly facilitates the study of the machinery underlying its progress, and may 
provide insights into the molecular mechanisms governing the polarized transport of cargo-
containing vesicles to the leading edge in a migrating cell during focal adhesion assembly. We 
therefore used a cell spreading paradigm in efforts of further characterize the molecular 
pathways that drive migration.  
1.2.2 Adhesion and signaling events during cell spreading  
 
Cell spreading can be roughly defined to proceed in three stages: (i) the early phase 0 (P0), 
characterized by slow spreading where cells make initial contacts with the extracellular surface; 
(ii) phase 1 (P1) characterized by a rapid increase in cell-attachment area and the rapid extension 
of lamellipodia, with weak contractions and homogenous edge velocity; and finally (iii) phase 2 





more heterogeneous edge behavior (Dubin-Thaler et al., 2004; Dubin-Thaler et al., 2008; 
Gauthier et al., 2011; Giannone et al., 2004).    
The early phase begins with integrin mediated cell adhesion. It was proposed about 30 
years ago that a tetrapeptide  “L-arginyl-glycyl-L-aspartyl-L-serine” sequence within the matrix 
protein fibronectin (which is also found  in other proteins of the extracellular matrix) constituted 
the minimal recognition site for integrins in cell attachment (Pierschbacher and Ruoslahti, 1984). 
Today it is known that this sequence mediates binding for roughly one third of the known 
integrin heterodimers as other integrins  have been shown to require auxiliary binding sites 
[reviewed in (Salsmann et al., 2006)].  
Following the binding of integrin to its substrate on the cell matrix, signaling is initiated towards 
ends of establishing a cytoskeletal connection. The Src family of protein kinases (SFK) appears 
to be one of the earliest mediators of this initial signaling (Zhang et al., 2008). These are a family 
of non-receptor tyrosine kinases with numerous cytosolic targets including nuclear and 
membrane proteins (Amanchy et al., 2009; Belsches et al., 1997).  In one model, SFK-linked 
signaling is concurrent with the initiation and mobilization of actin polymerization (Zhang et al., 
2008). After initial spreading, actomyosin contraction is activated leading to rapid actin 
retrograde flow near the cell periphery. It is postulated that this rapid radial flow of actin (which 
also entraps microtubules inwards by a retrograde pulling force (Burnette et al., 2007) is driven 
by unlinked myosin II contractions as adhesion contacts (which would otherwise provide an 
anchor to myosin contractions) are relatively weak and unstable at this stage of spreading (Zhang 
et al., 2008). Focal adhesion kinase (FAK), is another cytosolic non-receptor tyrosine kinase 
(typically found in integrin-rich adhesion sites) that is implicated in the turnover of cell contacts 





motif that is recognized by the SH2-domain containing proteins, such as Src-family kinases, and 
in one model, binding of cellular Src to FAK initiates signaling (Mitra et al., 2005). It is inferred 
from one study that FAK-Tyr 397 phosphorylation occurs after myosin II contractility in 
spreading cells since FAK-Tyr 397 phosphorylation (and thus its activation) was shown to be 
dependent on contractility (Zhang et al., 2008).     
Signaling induces the recruitment of accessory and bridging proteins such as vinculin, tensin, α-
actinin and talin to the cytoplasmic side of most integrins (Defilippi et al., 1999).  Of these, talin 
has been reported to act as an adaptor molecule, binding simultaneously to both actin and 
integrin. It is proposed that in this capacity talin begins to anchor uncoupled (myosin-induced) 
retrograde flowing actin, unto a stable adhered integrin molecule. The continuing myosin activity 
in this new anchored context will then translate into, stable contractile forces, where actin 
filaments tug against integrins producing traction and contractile forces (Zhang et al., 2008).   
Contractile forces could modify the topology of a protein and potentially altering its signaling 
state by exposing previously hidden interfaces, towards effector proteins (in a switch-like 
fashion), as is the case in one report by Sawada and colleagues where manual mechanical 
extension of bacterially expressed p130Cas (a Srk kinase effector) resulted in increased 
phosphorylation of this protein (Sawada et al., 2006).  
The signaling events initiated at integrins, include stimulation of Ras and Map kinases, protein 
kinase C, as well as the Rho family of monomeric GTPases towards ends of focal adhesion 
maturation and localized remodeling of the actin cytoskeleton (Clark and Brugge, 1995; 
Defilippi et al., 1999; Hemler, 1998; Howe et al., 1998; Keely et al., 1998; Schwartz et al., 





The Rho GTPases Rho, Cdc42, and Rac, are widely known to induce stress fiber 
organization, and actin organization in filopodia and lamellipodia respectively. When fibroblasts 
in culture adhere to fibronectin, they begin to spread and organize actin into peripheral filopodia 
and lamellipodia with the occasional focal contact present at the cell edges.  Data suggest a 
prominent role for Rac and Cdc42 in these early spreading processes. One representation 
describes that a possible molecular link between integrins and Rac may involve a protein called 
Dock180 (Dedicator of  cytokinesis 180) (Brugnera et al., 2002). This protein is phosphorylated 
upon cell adhesion and binds to adaptor molecules like p130Cas (described above) (Nojima et 
al., 1995), and p125FAK (Chen et al., 1995) but in addition, it has also been shown to bind to 
and activate Rac (Kiyokawa et al., 1998; Nolan et al., 1998). Thus in one model, the targeting of 
Rac to attachments sites may be by a mechanism where talin is first recruited to and binds to the 
cytoplasmic side of integrin. Talin, then associates with p125FAK (Chen et al., 1995), which in 
turn binds p130Cas, which recruits Doc180 to a complex at the adhesion site, primed to activate 
Rac (Defilippi et al., 1999) (see Fig. 1). Dock180 activation of Rac requires the interaction with 
its binding partner ELMO (Engulfment and Cell Motility), which together is thought to function 
as an unconventional two-part exchange factor (GEF) for Rac (Brugnera et al., 2002). Rac may 
also be stimulated through interaction with the Rac GEF TIAMI (Worthylake et al., 2000) and 
Vav (Crespo et al., 1997)-a proto-oncogene which contains membrane localization motifs (PH 
domains) that may aid in accurately localizing Rac activity to rafts (Balasubramanian et al., 
2007).   
An alternative pathway for Rac recruitment is through the adaptor protein zyxin, which is 
recruited to integrins through interaction with the actin binding protein α-actinin and may help 





activates Rac (see Fig.1 ) (Defilippi et al., 1999).   After Rac is recruited, its signaling promotes 
the activation of WASP and SCAR/WAVE (Wiskott-Aldrich syndrome protein)-family verprolin 
homologous protein) proteins, which act as powerful switches that stimulate actin nucleation 
through the Arp2/3 complex (Eden et al., 2002; Millius et al., 2012; Patel et al., 2008). 
During spreading, if at all contact with the extracellular matrix is not established, the 
lamellipodia will recoil forming ruffles (for review see (Defilippi et al., 1999). In an analogous 
pathway, CDC42 has been shown, along with PI(4,5)P2 to activate WASP mediated stimulation 
of actin polymerization through the Arp2/3 complex (Higgs and Pollard, 2000; Rohatgi et al., 
2000).  
Surprisingly, it was determined that Rho activity was in-fact down-regulated during the initial 
phases of cell spreading. Taking advantage of a biochemical assay to determine Rho activity, it 
was found that adhesion elicited an initial transient inhibition of Rho activity in Swiss 3T3 cells 
bound to fibronectin, followed by a later phase of Rho activation, peaking at about 60-90 
minutes post adhesion (Ren et al., 1999). This initial phase of Rho inhibition was consistent with 
rapid spreading whilst the delayed activation was synonymous with the formation of stress fibers 
and focal adhesions. This led to the hypothesis that the initial inhibition of Rho activity is to 
preclude the premature formation of stress fibers and subsequently myosin contractile forces and 
static focal adhesions that would act to impede cell spreading at its early stages (Wakatsuki et al., 
2003).  
1.2.3 Membrane exocytosis during cell spreading  
 
After a period of cell attachment and the formation of initial contacts, cells enter phase (P1), 
which is characterized by a rapid increase in cell-attachment and membrane addition (Dubin-





plasma membrane is inelastic and physically limits cell shape and area. Spreading therefore 
proceeds first by the stretching and flattening of membrane folds, and this unfolding of 
membrane reservoirs may permit spreading up to a point where they become depleted, after 
which spreading will proceed only by the addition of new membrane from intracellular stores 
(Gauthier et al., 2011; Gauthier et al., 2009). Membrane tension has been proposed to be a 
trigger for exocytosis, and in an elegant series of experiments, Gauthier and colleagues 
demonstrate that an artificial increase in plasma membrane tension stopped lamellipodia 
protrusion whist triggering an exocytic burst, leading the authors to suggest that plasma 
membrane tension may be used as a global physical parameter to regulate cell motility (Gauthier 
et al., 2011). This exocytic event is marked by a dramatic increase in the plasma membrane area 
of about 50% through activation of exocytosis and by the addition of single vesicles to the 
plasma membrane (Gauthier et al., 2009). The determination of the major source of this 
membrane was the subject of one study where it was demonstrated by TIRF analysis, that the 
exocytic frequencies of various fluorescent markers with the plasma membrane during spreading 
was greatest for GPI-labeled vesicles, implicating a recycling endosomal-specific compartment 
distinct from that labeled by the transferrin receptor (Gauthier et al., 2009). Similar conclusions 
were reached in an independent study using immunofluorescent techniques which showed that 
this compartment could be labeled by cholera toxin B, a probe which binds GM1, i.e a 
ganglioside enriched in the ectoplasmic/luminal leaflet of lipid rafts (Balasubramanian et al., 
2007). In this study it was demonstrated that upon spreading, rafts exit this compartment and are 
trans-located to the plasma membrane along microtubule tracks for their insertion into the 





remodel and spread anterogradely due to the slowing down of actin retrograde flow (as discussed 
above).  
Studies to elucidate the underlying machinery driving this exocytic event (also one of the goals 
of this thesis project) have suggested that this pathway may be dependent on Arf6 and 
Rab11(Balasubramanian et al., 2007) as well as Myo1c (Brandstaetter et al., 2012).  
Myosins are a large family of motor proteins that derive energy from ATP hydrolysis to 
bind and translocate along actin filaments (Foth et al., 2006), and they perform a range of 
functions including serving as transporters and modulating tension (Krendel and Mooseker, 
2005). One member of the myosin family Myo1c has been determined to be a lipid raft-
associated motor protein specifically involved in the delivery of lipid-raft-associated 
glycosylphosphatidylinositol (GPI)-linked cargo proteins from a peri-nuclear  recycling 
compartment to the cell surface (Brandstaetter et al., 2012). The targeting of this motor to 
membranes was proposed to involve direct binding to the phosphoinositide phosphatidylinositol-
4,5-bisphosphate PI(4,5)P2 via its putative pleckstrin homology domain (Hokanson et al., 2006; 
Hokanson and Ostap, 2006; McKenna and Ostap, 2009). This motor protein may promote tubule 
formation by anchoring and pulling membrane along actin filaments which are then transported 
by kinesins to the cell surface (Brandstaetter et al., 2012). It is also thought to participate at the 
final exocytic stages in navigating vesicles past the cortical actin meshwork beneath the plasma 
membrane (Brandstaetter et al., 2012). Myo1c-mediated raft exocytosis is critical for cell 
spreading (Brandstaetter et al., 2012).   
Part of the significance for transporting rafts to the plasma membrane is that in addition 
to partially supplying the membranous demands of an expanding plasma membrane, the rafts 





the plasma membrane to facilitate spreading.  Some of these proteins include Rac1 (which 
localize to lamellipodial edges within rafts), Rho and CDC42 (already discussed above) (del 
Pozo et al., 2004; Golub and Pico, 2005; Manes et al., 1999; Vasanji et al., 2004). Rafts also bear 
regulatory proteins that facilitate their own transport to the plasma membrane as is the case with 
the small GTPase RalA which has been shown to mediate exocytosis of rafts to the plasma 
membrane. In one study, inhibiting RalA (by expression of inhibiting peptides) inhibits integrin-
dependent membrane raft exocytosis (Balasubramanian et al., 2010). This RalA-mediated 
transport was furthermore determined to be dependent on the exocyst complex.  
The exocyst complex is an octameric complex (consisting Sec3, Sec5, Sec6, Sec8, Sec10, 
Sec15, Exo70, and Exo84) that directs post-Golgi complex vesicle targeting and tethering to the 
plasma membrane (He and Guo, 2009; Liu and Guo, 2012) (Fig. 2). RalA was shown to mediate 
the assembly of the full exocyst complex, by coordinating dual subunit interaction at a 
Sec5/Exo84 membrane interface (Moskalenko et al., 2003). These and other studies, implicate 
RalA and the exocyst complex in adhesion-dependent trafficking of lipid rafts (Balasubramanian 
et al., 2010).    
1.2.4 The final phase of cell spreading  
 
When adhesive processes are finished and cells have spread out over most of their final area, 
they then enter the final stage of spreading (Dubin-Thaler et al., 2004; Dubin-Thaler et al., 2008; 
Gauthier et al., 2011; Giannone et al., 2004) which is marked by periods of contractions and 
stable adhesion formation, slower spreading and a more heterogeneous edge behavior. The 
ensuing establishment of mature focal adhesions requires additional stimuli and signaling, 
including the activation of PKC (protein kinase C, PTKs (protein tyrosine kinases) such as 





Rho is a key player in the organization of stress fibers and the establishment of focal 
adhesions (Hall, 1998).  As discussed above this function is not conducive to dynamic spreading 
and as such, Rho is inhibited during the early phases of spreading. However during the later 
stages, the protein is reactivated to induce the assembly of actin stress fibers and this done 
primarily by bundling actin filaments, rather than by actin polymerization (Machesky and Hall, 
1997).  
There are two coordinated mechanisms by which activated Rho induces stress fiber 
organization and myosin induced contractility (in non-muscle cells) (Defilippi et al., 1999)(Fig. 
3). The first mechanism leads to the recruitment of profilin (an actin binding protein), for the 
restructuring of the actin cytoskeleton, near sites of Rho activation. Profilin is recruited to the 
sites of Rho activation by the Rho effector p140mDIA (mammalian diaphanous) (Narumiya et 
al., 1997; Watanabe et al., 1997). The second mechanism leads to the induction of myosin 
binding to pre-formed actin filaments for subsequent contraction. Actin binding of myosin is 
triggered when myosin is phosphorylated at its regulatory light chain by myosin light-chain 
kinase (MYLK) (Gao et al., 2001), which is in turn a target of the Rho effector, ROCK (Rho-
associated protein kinase) (Matsui et al., 1996) (Fig. 3). Rock also acts to increase MYLK 
phosphorylation by inhibiting phosphatase activity on MYLK activity (Kimura et al., 1996).  
This dual Rho activity induces stress fiber formation, contractions and the development of stable 
anchoring focal adhesions at the final stage of spreading.  
 






Arf6 has been implicated in the adhesion-dependent post endocytic recycling of rafts to the 
plasma membrane (Balasubramanian et al., 2007) and consequently cell spreading (Palacios and 
D'Souza-Schorey, 2003; Prigent et al., 2003; Song et al., 1998), but the specific contribution for 
Arf6, as well as the component parts of the machinery by which it mediates this effects is not 
clearly understood. Our lab has generated mice genetically manipulated for the acute deletion of 
the Arf6 gene in vitro. Thus in this project we have sought to more fully define the contribution 
of Arf6 in spreading using a mouse genetic approach.  
1.3.1 Introduction to the Arf family of small GTPases 
 
Arf belongs to the Ras superfamily of small GTPases, a group of guanine nucleotide-binding 
proteins, consisting of nine major families including Rab, Ran, Ras, Rad, Rap, Rit, Rheb, Rho 
and Arf. Arf comprises a family of approximately 20kDa guanine nucleotide-binding proteins, 
and its activity was first discovered in purified rabbit liver membranes (Kahn and Gilman, 1984), 
where it was found to be one of several cofactors responsible for the toxic effects of cholera-
toxin, a processes which includes the ADP-ribosylation (a signaling biochemical reaction 
involving a post-translational addition of one or more ADP-ribose, sugar moieties to a protein) of 
the α-subunit of hetero-trimeric G proteins  s (Gs) (Welsh et al., 1994). Today, Arf proteins have 
thus far been widely implicated in trafficking functions, actin cytoskeleton remodeling and cell 
morphogenesis (Donaldson and Jackson, 2000; Turner and Brown, 2001).  
Similar to other Ras-related GTP-binding proteins, Arf proteins bind to and cycle between GTP 
and GDP guanosine nucleotides, and this renders them in active and inactive confirmations 
respectively.  






A number of Arf genes were revealed in experiments analyzing the Arf activity that was found to 
stimulate cholera toxin-mediated (Gsα) ADP ribosylation (see above). The importance of Arf 
proteins is reflected in the fact that all known eukaryotes have at least one ortholog of the Arf 
family members which consists of Arf 1,2, 3, 4,5 and 6 (Gillingham and Munro, 2007). These 
are classified into three classes based on primary amino-acid sequence identity.     
Arf1, 2 and 3 constitute the class 1 members and of these proteins, Arf1 has been the 
most thoroughly studied and best characterized isoform. It has been shown to regulate membrane 
trafficking at multiple sites within the cell especially between the endoplasmic reticulum (ER) 
and Golgi apparatus where it recruits COP1 to pre- and cis-Golgi structures. It has also been 
shown to regulate AP1, 3, 4 and GGA (Golgi-localizing, gamma-adaptin ear homology domain, 
Arf-binding protein)  coat adaptors to the trans-Golgi network (TGN) (and endosomal) 
membranes (Antonny et al., 2005; Bonifacino and Glick, 2004; Donaldson et al., 2005; Spang, 
2002). Arf1 and Arf3 differ in only seven amino-acids clustered at the N and C termini and 
accordingly function very similarly (Donaldson and Honda, 2005).  
Arf4 and 5 were identified through sequence homology studies (Monaco et al., 1990; 
Tsuchiya et al., 1991) and they comprise the class II enzymes. There is evidence that Arf5 
functions in recruiting GGA (coat adaptor) mediating coat formation at the Golgi (Claude et al., 
1999; Kawamoto et al., 2002; Takatsu et al., 2002).   
Arf6 is the least-conserved and most structurally divergent amongst the Arf family 
members, and the sole member of the class III. It shares 66% amino-acid identity with Arf1, and 
is implicated in a variety of membrane trafficking processes, as well as in signaling roles and 
actin remodeling at the plasma membrane (Cavenagh et al., 1996; D'Souza-Schorey et al., 1995; 





In addition to the Arf proteins, eukaryotes also contain Arf-like proteins, or Arls, which 
are a distantly-related family of G-proteins who structurally resemble the Arf proteins, but whose 
functions are poorly understood.  Other more distantly related proteins include (ArfRP1) and 
SAR1p (secretion associated and Ras-related protein-1) (Burd et al., 2004; Gillingham and 
Munro, 2007; Kuge et al., 1994; Mueller et al., 2002) see also table1 for functional details for the 
Arls and SAR1p proteins and their orthologs). Sar1p, a core component of the COPII coats was 
shown in elegant work by Lee and colleagues to be able to directly initiate membrane curvature 
and deformation during vesicle biogenesis by insertion of an N-terminal amphipathic helix into 
lipid membranes, thus coupling membrane curvature with cargo capture (Lee et al., 2005). 
 
1.3.3 Arf protein expression  
 
Arf proteins are ubiquitously expressed proteins, found in all eukaryotes and are highly 
conserved with remarkable fidelity from the protozoan Giardia lamblia to mammals. This 
Giardia which is an early-divergent protist, lacks Ras representatives, and this indicates an 
earlier phylogenic origin for the Arf family members relative to the other G-protein family 
proteins (D'Souza-Schorey and Chavrier, 2006; Li et al., 2004; Murtagh et al., 1992).   
1.3.4 Arf structure 
 
The basic primary structure of Arf consists of an N-terminal amphipathic helix (which is 
myristoylated within the second N-terminal glycine residue-a modification critical for membrane 
binding) and two switch nucleotide-binding regions that are linked by a mobile inter-switch 
region (Fig. 4a)(Amor et al., 1994). The molecular structures of mammalian Arf1 and Arf6 have 





a conformational mechanism, where GTP-binding by the switch regions, induces the inter-switch 
region to displace the N-terminal amphipathic helix out of a resident pocket (that it occupies in 
the GDP-bound form see Fig. 4b; modeled  for Arf1) and rather to be displayed in a membrane-
binding-friendly conformation (Amor et al., 1994; Gillingham and Munro, 2007). A comparable, 
yet distinct mechanism governs Arf6 nucleotide exchange, and membrane binding as both 
proteins share ~70% sequence identity with almost identical switch sequences. A shorter N-
terminal linker region in Arf6 distinguishes this protein in the manner by which it binds 
nucleotides, and this difference is thought to provide a structural basis for how Arf1 and Arf6 are 
discriminated by their respective distinct exchange factors in cells (Menetrey et al., 2000).  
Other structural features between Arf1 and Arf6 serve to direct membrane localization in 
cells. Arf1for example, bears a unique 16-amino acid sequence that specifies Golgi targeting 
(Honda et al., 2005) and mediates binding to the ER-Golgi SNARE membrin, whereas for Arf6 
targeting information is contained within the c-terminal half of the protein, as a fusion of this 
region to the n-terminal part of Arf1 was sufficient to confer Arf6-like localization patterns to 
Arf1 (Al-Awar et al., 2000). Arf6 also in contrast to the other Arf proteins is thought to carry a 
high positive surface charge (due to its predicted pI>8.0, relative to that of the other Arfs which 
range from 6.0 to 7.0) which may facilitate its association with membrane-generally of negative 
charge (Donaldson and Honda, 2005). 
1.3.5 Arf activity is primarily controlled by GAPs and GEFs 
 
The intrinsic ability for Arf proteins to hydrolyze GTP to GDP as well as exchange GDP for 
GTP occurs very slowly under physiological conditions, and as a result require accessory 
GTPase-activating proteins (GAPs) (table 2) and guanine nucleotide-exchange factors (GEFs) 





In vitro, there appears to be some level of promiscuity between Arf-specific GEFs and GAPs for 
different Arf proteins, as is the case with the Arf GEF, ARNO (Arf nucleotide-binding-site-
opener) which has been reported to be a GEF for both Arf1 (Chardin et al., 1996) and Arf6 
(Frank et al., 1998a). Furthermore, it is known that the switch sequences between Arf1 and Arf6 
(which are critical for interaction with effector proteins) are rather quite similar in structure 
between the two proteins (Menetrey et al., 2000). Nevertheless, the functions of Arf1 and Arf6 
do not overlap, as Arf6 unlike Arf1 is not implicated in coat formation at Golgi, but rather in 
actin-rearrangement and vesicular trafficking at the plasma membrane and endosomes. These 
findings raise questions as to how this level of specificity is achieved in cells. One possible 
answer may lie within differences in the structural arrangements of the switch regions between 
the two proteins. Crystallography comparisons reveal that that sequence differences that lie 
outside the switch regions of Arf1 and Arf6 impact structural properties at the switch regions 
which result in distinctive nucleotide binding properties large enough to discriminate interactions 
between cognate GAPs and GEFs (Gillingham and Munro, 2007). Additionally, these GEFs and 
GAPs may in turn be differentially localized subcellularly, thus restricting the engagement of 
Arf1 and 6 only at distinct sub-cellular locales (D'Souza-Schorey and Chavrier, 2006). This may 
help to prevent functional overlap between these proteins in cells. In epithelial cells for example, 
ARNO (ARF GEF) is restricted to the apical membrane compartment, where it could specifically 
mediate the activation of Arf6, which also resides at the plasma membrane (Chardin et al., 1996). 
1.3.6 GTP/GDP cycling is critical for Arf function  
 
Arf proteins cycle between the GTP and GDP-bound confirmations and like all GTPases the 
ability to cycle is critical to the proper functioning within the cell. Thus experimentally, a 





target this normal cycling ability. Brefeldin A, for example is a fungal metabolite that inhibits 
guanine-nucleotide exchange (GEF activity) in a subclass of Arf GEF proteins, by trapping GDP 
exchange in an inactive abortive intermediate complex (Jackson and Casanova, 2000). Arf6 
GEFs in contrast with other Arf GEFs, are generally immune to this molecule, and accordingly, 
it has been used routinely as a tool to discriminate Arf6 activity from that of the other Arf 
proteins.  Arf6 specific functions in turn, have been widely sorted out by employing the use of 
mutants, defective in GTP binding (T27N) and/or GTP hydrolysis (Q67L). For example, on one 
hand, Arf6(Q67L) has been found mainly at the plasma membrane and invaginated pits and 
forms large terminal vacuoles that trap molecules such as beta1-integrin, and MHC1 (major 
histocompatibility complex class I) that otherwise traffic through an Arf6 endosomal 
compartment (Brown et al., 2001). These enlarged endosomes are highly decorated with 
PI(4,5)P2 and it is thus proposed that Arf6 inactivation and the subsequent hydrolysis of 
PI(4,5)P2 is an obligate step for normal trafficking through this pathway, since over expression of 
phosphatidylinositol-4-phosphate 5-kinase (PIPkinase; an enzyme that generates PI(4,5)P2 
induced a similar phenotype (Brown et al., 2001). It is thought therefore that under physiological 
conditions, Arf6 must remain inactive after endocytosis, until vesicles are posited to be recycled, 
where Arf6 must be reactivated in order to stimulate the lipid enzyme phospholipase D 
(described in chapter 2) towards recycling ends (Donaldson et al., 2009). The GTP binding 
mutant (T27N) on the other hand is thought to localize to tubulovesicular structures representing 
the pericentriolar recycling compartment and acts to block the recycling of cell surface 
molecules back to the cell surface (Peters et al., 1995). Finally a fast cycling mutant has also 
been described (Santy, 2002), which was reported to spontaneously bind and release GTP faster 





1.4 ARF6-SPECIFIC FUNCTIONS 
1.4.1 Arf6 in membrane transport at the plasma membrane 
 
Unlike Arf1, Arf6 neither localizes to the Golgi, nor does it appear to contribute to Arf-
associated activities there, but rather is a major regulator of membrane traffic to and from the 
plasma membrane and of actin dynamics. These diverse cellular functions indicate that Arf6 may 
be activated at multiple discrete sites at the cell surface and along its endocytic itinerary, where it 
may influence plasma membrane structure and sorting of membrane proteins (reviewed in 
(D'Souza-Schorey and Chavrier, 2006). Some of these roles may be mediated by its effects on 
phospholipid metabolism. In this regard Arf6 has been suggested to be able to bind to and 
activate lipid enzyme phospholipase D (PLD) (Melendez et al., 2001; Powner et al., 2002) as 
well as PIPKinase (Colley et al., 1997b; Funakoshi et al., 2011) to generate phosphatidic acid 
(PA) and PI(4,5)P2, respectively.  
PLD localizes to sites of actin remodeling, is regulated via interactions with actin 
modifying proteins like α-actinin (an actin bundling protein) and gelsolin (and actin severing 
protein) (Lee et al., 2001), which may serve to position PLD where locally produced PA may act 
as a cofactor for PIPKinase stimulation which will in turn will generate PI(4,5)P2 as has been 
shown in vitro (Honda et al., 1999). These acidic phospholipids lipids can impact the topology of 
their native membranes, either directly, or by the recruitment of other proteins. Phosphatidic acid 
for example is a fusogenic lipid with a cone shaped topology, which confers on it the native 
capacity to physically deform membranes (Kooijman et al., 2003)(described further in chapter 
2). It can also serve as a binding substrate for other signaling proteins to these regions. PI(4,5)P2 
on the other hand can recruit components of the actin polymerization machinery including 





cytoskeleton (Yin and Janmey, 2003). This lipid is concentrated in the plasma membrane where 
it participates in many events including endocytosis (Di Paolo and De Camilli, 2006). 
1.4.2 Arf6 mediated endocytosis  
 
Arf6 mediated activation of PI(4,5)P2 synthesis may also directly impact other plasma membrane 
activities including clathrin mediated endocytosis as it is now well established that PI(4,5)P2 is a 
bona fide regulator of this pathway (Di Paolo and De Camilli, 2006; Doherty and McMahon, 
2009). Indeed recombinant Arf6-GTP has been shown to interact with the clathrin adaptor 
protein AP-2 and together with PI(4,5)P2 synergistically promote its recruitment to artificial 
membranes (Paleotti et al., 2005). Similarly, Arf6 was found to stimulate PIPkinase activity 
resulting in increased levels of PI(4,5)P2 on synaptic membranes and a subsequent recruitment of 
AP-2 (Krauss et al., 2003). Altogether this supports a model where Arf6 mediated activation of 
PI(4,5)P2 facilitates coat assembly. In cells this Arf6 activity may be regulated by GEFs and 
GAPs. For example in polarized epithelial MDCK ( Madin-Darby canine kidney)  cells, SMAP1, 
an ArfGAP has been shown bind clathrin heavy chain (Tanabe et al., 2005) and to regulate 
clathrin dependent endocytosis at the apical and basolateral membranes (D'Souza-Schorey and 
Chavrier, 2006).  Furthermore expression of Arf6 mutants altered the morphology of clathrin-
coated pits at the apical plasma membrane in these cells (Honda et al., 1999).    
In addition to the clathrin-dependent mechanisms described above, Arf6 has also been 
implicated in the endocytosis of other receptors that are internalized through clathrin independent 
mechanisms. These include MHC class 1 (major histocompatibility complex class I protein), 
M2-muscaranic acetylcholine receptors, β1 integrin receptors, the IL-2 receptor alpha subunit 





adrenergic receptor and the luteinizing hormone receptor (Claing et al., 2001; Donaldson, 2003; 
Mukherjee et al., 2000; Naslavsky et al., 2003; Radhakrishna and Donaldson, 1997). 
G-protein coupled receptors (GPCRs) are a large family of cell surface transmembrane 
receptors, that sense and transmit extracellular cues into signaling pathways within the cells and 
ultimately to cellular responses. These are crucial players in tumor growth and metastasis 
(Dorsam and Gutkind, 2007). The diversity of GPCRs, is matched by the multiplicity of signals 
that they transmit and in turn the numerous signaling pathways that are activated by them. In 
response to prolonged agonist stimulation GPCR’s are however able to regulate their own 
responsiveness, by promoting signaling which culminates in their removal from the plasma 
membrane (Freedman and Lefkowitz, 1996). Agonist stimulation triggers the recruitment of 
cytosolic kinases called GRKs (G protein-coupled receptor family of kinases) (Premont et al., 
1995) which phosphorylate the receptors, creating binding sites for the recruitment of arrestins. 
Arrestins are a small family of signal transduction regulating proteins (Lefkowitz and Shenoy, 
2005; Moore et al., 2007) that are considered negative regulators of the GPCR signaling (Bohn et 
al., 1999). A role for Arf6 was demonstrated in the internalization processes of β2-adrenergic 
receptors (a GPCR), where, it was found in a complex with β-arrestin (Claing et al., 2001).  This 
was confirmed in experiments showing that modulating the activity of Arf6 by way of its GEFs 
and GAPs activity impacted the endocytosis of the receptor. It was found for example that β-
arrestin in addition to serving as a molecular link between the receptor and Arf6, also potentiated 
the activation of Arf6 by promoting the activity of its GEF, ARNO(Claing, 2004).  
In one proposed mechanism, ARNO is locally recruited to, and induces the release of 
negative inhibition mediated by bound arrestin, by promoting its release from the membrane and 





of Arf6 by means of overexpression of its GAP, GIT1 markedly reduced the internalization of 
the β2-adrenergic receptor (Claing et al., 2000). A dependence for Arf6 activity on the 
internalization of β2-adrenergic receptor was also shown in HEK 293 cells using mutant Arf6 
alleles (Claing et al., 2001). Finally similar results were also obtained for the leutinizing 
hormone receptor, another GPCR (Mukherjee et al., 2000).  
1.4.3 Arf6 in post endocytic sorting and recycling  
 
After internalization, Arf6 is inactivated and recycled back to the plasma membrane, whereas 
endocytosed cargo proceeds and merges with that endocytoced through the classical clathrin 
dependent pathway inside sorting endosomes (Brown et al., 2001; Naslavsky et al., 2003).  
Once in sorting endosomes, recycling could occur directly from this compartment in a 
“fast” recycling pathway, or through the peri-centriolar endosomal compartment which consists 
of a heterogeneous subset of endosomal populations (D'Souza-Schorey and Chavrier, 2006; 
Maxfield and McGraw, 2004).  In HeLa cells, Arf6 is associated with a distinct endosomal 
compartment that exists in parallel with the classical endosomes where the transferrin 
accumulates (Brandstaetter et al., 2012). Recycling through this pathway requires several 
proteins (including EPS15, EHD1, Rab22 and TRE17) (D'Souza-Schorey and Chavrier, 2006) 
and tubules from this compartment radiate from the juxtanuclear area and traffic several integral 
membrane proteins that lack AP-2 and clathrin sorting sequences (Naslavsky et al., 2003; 
Radhakrishna and Donaldson, 1997). These include MHC1 and E-cadherin (Paterson et al., 
2003) as well as GPI anchored proteins (Naslavsky et al., 2003; Radhakrishna and Donaldson, 
1997).     
In CHO cells Arf6 labels a similar tubular compartment that partially overlaps with the 





ACAP1 associates with these receptors and can regulate their recycling to the plasma membrane 
(Li et al., 2005). Similarly, EFA6 (exchange factor for Arf6) also regulates constitutive recycling 
through this compartment in a pathway that is dependent on PLD activity (Franco et al., 1999).   
The family of Rab GTPases are key regulators of intracellular trafficking functioning at 
various stages along the endocytic pathway (Zerial and McBride, 2001).  Rab11 is a key 
mediator of endocytic recycling, and regulates transport out of the recycling endosomal 
compartment towards various other sub-cellular locations including the TGN and the plasma 
membrane. Both Rab11 and Arf6 have been shown to bind a member of a family of effector 
molecules called Arfophilins or FIPs (specifically FIP3 (Hickson et al., 2003)-which binds to the 
switch 1 and 11 regions of Arf6 (Hickson et al., 2003; Shin et al., 2001) suggesting that FIP3 
may assist in coupling Arf6 activity to endocytic recycling. This recycling may in turn rely on 
PLD activity (Jovanovic et al., 2006; Padron et al., 2006) as well as the exocyst complex 
(described above) for directing and tethering vesicles to the plasma membrane (Prigent et al., 
2003). 
In addition to endocytic recycling, Arf6 may also have a role in regulated secretion as 
demonstrated in PC12, which are a specialized secretory adrenal chromaffin cell line (Aikawa 
and Martin, 2003; Caumont et al., 2000; Greene and Tischler, 1976; Liu et al., 2005; Vitale et al., 
2005).  In these cells calcium stimulation induces the association for Arf6 with large dense core 
granules that are docked at the plasma membrane (Galas et al., 1997), a processes which relies 
on the activity on PLD as expression of an Arf6 mutant (N481) which is unable to activate PLD, 
results in secretion inhibition. This suggests that PLD is a downstream effector of Arf6 in this 
pathway (Vitale et al., 2002b). 






In addition to its role in membrane trafficking, the ability of Arf6 in actin remodeling especially 
at the cell periphery, is now well recognized and this ability is central to its role in processes 
such as motility, tumor cell invasion, formation of membrane ruffles, neurite outgrowth, 
phagocytosis, cell spreading (reviewed in (D'Souza-Schorey and Chavrier, 2006; Schweitzer et 
al., 2011), and the generation of protrusive structures towards macropinocytosis (Radhakrishna et 
al., 1996). This ability to remodel actin was found to rely on two amino-acids within the switch 1 
region of the protein (Al-Awar et al., 2000).  Arf6 effects on the actin cytoskeleton may be 
mediated by PI(4,5)P2, which has been shown to influence actin polymerization by way of 
regulating the activity of several actin-binding proteins (Hilpela et al., 2004). The ability of Arf6 
to remodel the actin cytoskeleton may also be dependent on its ability to recruit active Rac to the 
plasma membrane (Caumont et al., 2000; Radhakrishna et al., 1999) which may function in 
synergy with lipid enzymes like PLD to coordinate actin rearrangement and cell motility (Santy 
and Casanova, 2001). This coordination between Arf6 and Rac1 is mediated in turn by a 
coordinated effect between their respective activators (GEFs) as in one report, it was shown the 
Arf6 GEF ARNO strongly co-localizes with Rac GEF, Doc180/Elmo and is consistent with a 
robust Rac activation in migrating MDCK cells (Santy et al., 2005). It has been further suggested 
that the recruitment of Rac1 to the plasma membrane may be due to Arf6-regulated trafficking of 
lipid raft which provide binding sites for Rac1 (Balasubramanian et al., 2007). 
Given this profound ability to impact the cytoskeleton, Arf6 activity in turn impinges on 
various physiological cellular events that rely on coordinated actin rearrangement, and changes 
in surface morphology, many of which are mentioned above (see table 4 and review 
(Brandstaetter et al., 2012). Arf6 was furthermore observed to play a role in the generation of 





spreading, wound healing, cell migration, and cell invasion (Donaldson, 2003; Radhakrishna et 
al., 1996). 
1.4.5 Arf6 in cell migration and motility 
 
Assays conducted with breast cancer cell lines and invasive melanoma cells, have demonstrated 
a requirement for Arf6 in the invasive potential of these cells, as depletion or expression of 
mutant alleles of Arf6 blocks cell invasion (Hashimoto et al., 2004; Tague et al., 2004). During 
metastasis, cells can be induced to dissociate from their neighbors and scatter. This integrity 
prior to dissociation is maintained through cell-cell as well as cell-matrix junctions, and in 
epithelial cells (not present in fibroblasts) these serve as a barrier to motility (Turner and Brown, 
2001).     
The disassembly of these cell-cell contacts is critical for acquisition of a migratory 
phenotype necessary for invasion, and is a processes that has been shown to rely on Arf6 
(D'Souza-Schorey, 2005). In hepatocytes cell scattering can be induced with the application of 
hepatocyte growth factor (HGF). In this process, induction leads to a sustained activation of 
Arf6, which (along with a concomitant initial inhibition of Rac1 activity) results in the 
internalization of adherens junctions proteins (Palacios and D'Souza-Schorey, 2003). This down 
regulation of Rac1 activity is mediated by Arf6 recruitment of the Rac1 kinase inhibitor (Nm23-
H1) which in MDCK cells has been shown to also promote dynamin-mediated endocytosis of 
adherens junctions and thus their disassembly (Palacios et al., 2002). The lysosomal targeting of 
E-cadherins has been proposed as a means of ensuring that cells do not reform contacts, but 
rather remain motile (Palacios et al., 2005). 






Consistent with its general role in actin mediated alterations in cell morphology, it is not 
surprising that Arf6 has also been implicated in cytokinesis during cell division. Cytokinesis is 
the final step of mitosis, where cell division results in the emergence of two daughter cells. This 
process is important for normal development and improper regulation can lead to pathological 
states, such as aneuploidy, a fragile state of genomic instability that has been linked to tumor 
formation and cancer (Driscoll and Gross, 2009).  During cytokinesis, actomyosin (a complex 
composed of actin and myosin-an ATP-dependent motor protein) contractions create a 
contractile ring that acts to cleave an elongated cell along an ingressing plasma membrane area 
called a cleavage furrow. Progressive ingression of plasma membrane at the cleavage furrow, 
culminates into deep invagination, where daughter cell are connected by a thin intracellular 
bridge, the center of which lies a dense transient region filled with cytoskeletal proteins and 
membrane called a mid-body (Paweletz, 2001). This structure is important for completing 
cytokinesis (Skop et al., 2004).  
Analysis of mitotic progression in HeLa cells revealed a transient spike in Arf6 activation during 
cytokinesis, which corresponded to its localization to the cleavage furrow and midbody prior to 
the separation of daughter cells (Schweitzer and D'Souza-Schorey, 2002).  Furthermore, 
depletion of Arf6 by siRNA (Schweitzer and D'Souza-Schorey, 2005), or expression of mutant 
alleles were shown to result in late stage cytokinetic defects and failure implicating a role for 
Arf6 (Montagnac et al., 2009; Schweitzer and D'Souza-Schorey, 2002, 2005). The contributions 
for Arf6 in this process is thought to involve Rab11, arfophilins, the exocyst complex (described 
above)  as well as the targeting of recycling endosomal and secretory (Golgi derived) vesicles to 
the cleavage furrow and mid-body area (Goss and Toomre, 2008; Gould and Lippincott-





directionally of endosomal movements may be mediated by the interactions of Arf6 with JIP4, a 
kinesin associated scaffolding protein which regulates endosomal traffic during cytokinesis 
(Montagnac et al., 2009). 
1.4.7 Arf6 in cholesterol efflux 
 
Proper endosomal traffic is critical to cell vitality and misregulation in this process can result in 
human disease. Niemann-Pick Type C (NPC) disease is a neurodegenerative disease, that affects 
1 in every 150,000 people  and patients diagnosed with the disease typically exhibit neurological 
symptoms which include tremors, epilepsy, psychosis and dementia (Chang et al., 2005; Garver 
et al., 2007; Klunemann et al., 2012). At the cellular level, this disease has been linked to a 
defect in cholesterol storage. Cholesterol is acquired exogenously primarily through LDL 
mediated endocytosis (low-density lipoprotein)-a particle that enables transport of fat 
molecules), which upon internalization is directed to the late endosomes and lysosomes where it 
is hydrolyzed, releasing free-cholesterol which moves to the ER, or back to the plasma 
membrane (Liscum and Sturley, 2004). The fate of cholesterol, once internalized, and its 
homeostasis within the cells is regulated by vesicular transport events, and multiple sensory and 
feedback mechanisms, that modulate uptake and efflux accordingly. NPC arises from mutations 
in the NPC genes (NPC1 and NPC2) both of which are involved in the egress of lipids 
(particularly cholesterol) from late endosomes and lysosomes where they accumulate and create 
disruptions in normal cholesterol homeostasis (Chen et al., 2001; Choi et al., 2003; Cruz and 
Chang, 2000; Ikonen and Holtta-Vuori, 2004; Wang et al., 2007). In one study, Arf6 was found 
to be able to relieve lipid accumulation in fibroblasts derived from NPC patients, and also in 
HeLa cells treated with a drug U18666A that mimics the NPC phenotype (Schweitzer et al., 





These findings support a model, where Arf6 mediated stimulation of endocytic recycling rescues 
cholesterol efflux and restores homeostasis in this diseased setting (Schweitzer et al., 2011). 
1.4.8 Arf6 function in other organisms  
 
The yeast Arf6 homologue, Arf3 is was found to be involved in regulating endocytic events at 
the plasma membrane, in a pathway that involves PI(4,5)P2 production and actin remodeling 
(Smaczynska-de et al., 2008).  Arf3p localizes to dynamics spots at the plasma membrane in this 
organism (consistent with a function in the endocytic machinery). Deletion of this gene results in 
decreased levels of plasma membrane PI(4,5)P2 levels whilst elevated levels results in increase 
number of endocytic events (Smaczynska-de et al., 2008). Other studies show that this gene is 
also involved in the budding and organization of actin cable and cortical patches in 
Saccharomyces cerevisiae (Tsai et al., 2008). 
In Drosophila melanogaster the Arf6 homologue (Arf1F) has been shown to play a role in 
cytokinesis in spermatocytes and disruption of this gene causes a failure in cleavage furrow 
completion (Tsai et al., 2008). Other studies implicate this gene in the eye patterning functions in 
Drosophila.  Finally, information regarding the functions of Arf6 homologue in C.elegans 
(F45E4.1/arf-1.1) is virtually uncharted.  
 
1.5 EXPERIMENTAL OVERVIEW 
 
It is clear from the studies mentioned above, that Arf6 functions in many cellular processes vital 
to normal cell physiology. Although much insight into these functions has been garnered through 
the use of dominant active and negative alleles of the gene, it is generally warned that 





Arf6, as is the case with all other small GTPases, is most faithfully preserved, only in 
circumstances where the ability to cycle is also preserved. Thus, safer interpretations may be 
derived from over-expression studies, using either the fast cycling Arf6 mutant described above 
(see also (Santy, 2002), or by expressing specific Arf6 GEFS and GAPS, or by gene depletion 
approaches using siRNA. In a more elegant system to these, our lab, for our studies have 
generated conditional Arf6 knockout mice from which we have derived and immortalized 
fibroblasts. These are characterized in the assays described later below.  
1.5.1 Arf6 KO mice are embryonically lethal 
 
Complete ablation of Arf6 in mice results in embryonic lethality, unlike heterozygous mice, 
which are healthy and fertile (Suzuki et al., 2006). The knockout mice die at about mid-gestation 
(see table 5) which indicates that Arf6 is essential for normal development. The most obvious 
defect in these mice is an embryonic abnormality in the liver.  These mice also exhibit edema 
and anemia which occurs in the mid-to late-gestational periods.  
The livers appear to be dramatically smaller than their WT counterparts and aberrant in structure. 
A careful analysis using hematoxylin and eosin staining revealed that these livers were 
hypocellular, and marked by increased apoptosis as determined by TUNEL staining and Western 
blot analysis. The authors proposed that the increased apoptosis may be secondary to a failure in 
epithelial cell sheets to elongate and branch into a hepatic chord (a liver cell layer) and is an 
event which aberrantly terminates in apoptosis in the null organ.    
This aberrant phenotype was shown to be successfully recapitulated in an in-vitro system for the 
formation of hepatic chord-like structures, where HGF (hepatocyte growth factor) mediated 
induction of these structures was impaired when applied to Arf6 KO hepatocyte cultures 





HGF induced cell scattering in MDCK cells (Palacios and D'Souza-Schorey, 2003). In this study 
it is proposed that Arf6 functions in synergy with Rac1, to promote the dissolution of 
intercellular adhesions, resulting in cell-cell dissociations and migration. Similar cell migration 
and motility pathways are suspected to be disrupted in this in-vivo model. Altogether these 
observations testify that the contributions of Arf6 are penetrant even to level of the organism.  
Due to the embryonic lethality limitation described in the model above, our lab has 
sought and successfully generated conditional Arf6 knockout mice. Parallel to the study 
described here, other efforts are underway to further characterize these mice in other in-vivo 
experimental settings and behavioral assays.  
1.5.2 The CreER system for conditional gene deletion  
  
The Cre integrase from bacteriophage P1 has become a powerful tool to permit control over the 
temporal and spatial regulation of gene expression in mice, and has provided a means to assess 
gene function in a diverse set of tissues  at both embryonic and adult stages (for a more detailed 
review of the Cre-loxP system and its evolution see reference (Feil et al., 2009). This 
recombinase catalyzes intramolecular recombination between two 34-bp DNA recognition 
sequences known as loxP sites (locus of crossing [x-ing]-over of bacteriophase P1) and if flanked 
(or “floxed”) around an essential exon of a target gene of interest, it will catalyze the precise 
excision of any interjacent sequences rendering a null allele in all cells where Cre is expressed 
and active. The delivery of Cre into the cells is achieved by crossing mice bearing floxed alleles 
of the target gene, with Cre-expressing transgenic mice (at the whole organism level, or under 
tissue specific promoters resulting in tissue specific gene deletion). In this system, since breeding 
and gamete shuffling, becomes the general inducer of Cre delivery into cells, one major set-back 





recombinase and gene excision. This is a disadvantage that may preclude analysis of gene 
function at later developmental stages for cases where gene deletion results in utero lethality. 
Thus in efforts to overcome this limitation, advancements were made to render post-delivered 
Cre, inducible.   
In this model system, Cre is fused to a mutated form the of the ligand binding domain of the 
estrogen receptor (Cre-ER), a genetic manipulation that renders the resultant expressed protein 
cytosolic (i.e., not nuclear; by means of sequestration by the heat shock protein HSP-90) and 
responsive, not to the former ligand estrogen, but to the cell permeant tamoxifen (Engelk et al., 
2001; Mattioni et al., 1994). Finally the administration of tamoxifen (either given to mice, or 
added to derived cultures) disrupts Hsp90 mediated cytosolic retention in cells and permits the 
translocation of Cre-ER to the nucleus where it can initiate recombination. Thus here in this 
system, gene deletion is rendered inducible in a temporal and spatial manner using tamoxifen as 
a trigger.  
 
1.6 RESULTS AND DISCUSSIONS 
1.6.1 Generation of Arf6 conditional KO mice  
 
Accordingly, our lab has generated, using the Cre-loxP system (described above) a conditional 
deletion mutant of Arf6 (Fig. 5) where MEFs derived and immortalized from mice embryos were 
pharmacologically induced (with tamoxifen) for Arf6 deletion in culture (Fig. 5a). Loss of Arf6 
was validated by PCR (Fig. 5b) using genomic DNA isolated from MEFs, which shows the loss 
of amplified product in the tamoxifen treated lanes of two different clones. This was furthermore 
confirmed by Western blot, where extracts prepared from tamoxifen (or vehicle (DMSO)-treated 





(Fig.5c). Loss of Arf6 immunoreactivity occurs over the course of approximately one week (Fig. 
6) with the largest decrease (of a 75%) occurring in just three days of drug treatment. This is 
followed by progressive protein loss of more than 98% on day 6, occurring in the absence of 
drug.  
1.6.2 Examining the expression levels of various proteins in response to Arf6 ablation  
 
Single gene ablations and resultant loss of protein expression and function, may result in 
compensatory changes in the expression levels of other proteins, in efforts to preserve normal 
cellular function. Thus since Arf6 is a multifaceted regulator of various vesicular trafficking 
events within the cell (see discussions above) we examined whether there were any alterations in 
the expression profiles of a selected group of trafficking-related proteins. Of those tested (Fig.7) 
only clathrin showed a moderate 20% increase the expression levels in the KO MEFs. This is 
consistent with other studies suggesting a role for Arf6 in mediating the assembly of the AP-
2/clathrin coat during clathrin mediated endocytosis (Paleotti et al., 2005) or may simply reflect a 
compensatory increase in clathrin-mediated endocytosis in the absence of Arf6-mediated 
endocytosis. 
1.6.3 Transferrin trafficking overview 
 
The transferrin receptor is a classic example of a receptor that utilizes the clathrin mediated 
endocytic pathway, and unlike many other kinds of receptors whose internalization, is regulated 
by ligand binding, nutritional receptors like the transferrin receptor are constitutively 
endocytosed. This receptor reversibly binds and delivers Fe
3+
 from sites of absorption and 
storage into tissues and cells. Part of the molecular mechanisms governing the sorting of 





(YXRF) on the receptor by cytosolic proteins that in turn mediate receptor internalization 
(Girones et al., 1991; Jing et al., 1990).  At the slightly alkaline extracellular pH of 7.4, iron 
binds to, transferrin (see Fig.8, step 1)-a major mammalian serum glycoprotein which in turn 
recognizes and binds to the transferrin receptor located at the surface of cells (Steere et al., 
2012). The iron-transferrin complex (known as ferric transferrin) is then endocytosed through 
clathrin dependent mechanisms (Fig. 8, step 2), and then enters the acidified environment of the 
endosomes (mediated by the action of ATP-dependent H
+
 pumps) (Fig. 8, step 3). In this 
environment, the acidic pH of the endosomal lumen triggers a conformational change in 
transferrin that causes it to disgorge bound iron inside the endosomes; but the iron-free 
transferrin molecule (known as apotransferrin) itself still remains attached at high affinity to its 
receptor (Dautry-Varsat et al., 1983).  Finally the apotransferrin/transferrin receptor complex is 
returned to the cell surface (Fig. 8 step 4) where the extracellular pH (7.4) induces dissociation of 
the complex (Dautry-Varsat et al., 1983).    
1.6.4 Transferrin uptake in Arf6 MEFs 
 
Since clathrin appeared to be slightly up-regulated in the KO MEFs, we subjected WT and KO 
MEFs to a transferrin uptake assay in other to monitor the endocytic rates of this receptor in 
these cells. Briefly, WT and KO cells were starved for one hour, and pulsed with biotin-labeled 
transferrin for different time points, at which point uptake was stopped with cold PBS. Surface 
bound probe was then stripped away with a mild acid wash. Cells were then washed and lysed, 
and extracts were prepared for monitoring internal levels of transferrin by western blot. 
Endocytic rates of the transferrin receptor were measured as a reflection of the total amount of 
internalized biotinylated transferrin, per unit time. Results show that internal levels of transferrin 





uptake kinetics (Fig. 9a ). The total levels of transferrin receptor was also similar between 
genotypes (see: Fig. 9b).  
1.6.5 Transferrin recycling in Arf6 MEFs 
 
EFA6 (exchange factor for Arf6) has been shown to stimulate the recycling of transferrin 
receptors (Padron et al., 2006). Accordingly in addition to uptake experiments, we assayed cells 
for transferrin recycling kinetics. Briefly cells were starved for 1hour and pulsed with transferrin-
biotin for another hour. Following this treatment, cells were then chilled on ice and surface 
bound labeled probe was removed by a mild acid wash. Cells were then chased with excess of 
unlabeled holo-transferrin for indicated time points (Fig. 10) after which they were washed and 
lysates were similarly prepared and probed for internal levels of transferrin. Consistent with the 
aforementioned study (Padron et al., 2006), Arf6 KO MEFs exhibited a statistically significant 
kinetic delay in the transferrin recycling with 34% more transferrin being retained in the KO 
MEFs at 15 minutes of recycling. This larger internal residual pool is not attributed to increased 
rates of uptake (as demonstrate in the uptake experiments). This is confirmatory to previous 
findings implicating a role for Arf6 in transferrin recycling (Padron et al., 2006).  
 
1.6.6 Epidermal growth factor receptor overview 
 
The epidermal growth factor receptor, like the transferrin receptor is another major prototype 
receptor that is internalized through the clathrin mediated endocytic pathway. Ligand binding to 
this receptor induces its dimerization, and subsequent phosphorylation (mediated by both 
receptor tyrosine kinases and by trans-autophospohorylation) recruits CBl (Cbl-interacting 





growth factor receptor (via its tyrosine kinase-binding domain) and promote its ubiquitination 
and subsequent endocytosis through the clathrin mediated pathway (Dikic, 2003; Dikic et al., 
2003; Joazeiro et al., 1999; Levkowitz et al., 1999; Pickart, 2000). The activated epidermal 
growth factor receptor is then removed from the cell surface and is sorted towards the lysosomal 
pathway in a process that involves ubiquitin (Futter et al., 2001), and a complex series of 
cytosolic proteins including the ESCRT complex (endosomal sorting complex required for 
transport), which targets the receptor into MVB’s (multivesicular bodies) (see Fig. 11) (Alberts 
et al., 2008).  Finally, MBV structures are then delivered to lysosomes where this cargo is finally 
degraded by acid hydrolases (Luzio et al., 2010). 
1.6.7 Epidermal growth factor receptor endocytosis in Arf6 MEFs  
 
As reported above an increase in the levels of clathrin expression in the KO MEFs, (see Fig. 7) 
warranted experiments that examined the trafficking dynamics of bona-fide clathrin trafficking 
cargo. In addition to transferrin which constitutively cycles, the epidermal growth factor receptor 
is mostly routed for degradation. We then tested the kinetics of epidermal growth factor receptor 
degradation in the Arf6 WT and KO MEFs. Briefly, cells were starved for 24hrs (a treatment 
which up-regulates surface expression of the receptor) and subsequently inoculated with ligand 
(100ng/ml epidermal growth factor), for the indicated time-points to induce receptor endocytosis 
and degradation. Cells were then harvested and lysed, and lysates were prepared and analyzed by 
western blot. Results indicate that there is no significant difference in the endocytic and 
degradation kinetics of this receptor between WT and KO MEFs (Fig. 12). Altogether, these 
results suggest that an up-regulation of clathrin expression (in the Arf6 KO MEFs) does not 
significantly affect the endocytic rates of these clathrin regulated receptors. One explanation is 





the existing pools transferrin and epidermal growth factor receptors (i.e, excess clathrin in the 
KO MEFs does not contribute towards increased endocytic rates). Clathrin has also been 
reported to form an unusual structure that lacks AP1, 2, and 3 and this structure is insensitive to 
BFA, but sensitive to the phosphatidylinositol 3-kinase inhibitor wortmannin. It has been 
assigned roles in concentrating and targeting ubiquitinated receptors such as EGFR to the 
lysosomes (Sachse et al., 2002). This however does not appear to provide a significant kinetic 
advantage for EGFR degradation in the Arf6 KO MEFs.  
1.6.8 Arf6 KO MEFs exhibit a kinetic delay in cell spreading  
 
Arf6 has been implicated in a wide variety of studies, to participate integrin mediated cell 
adhesion and spreading (Balasubramanian et al., 2007; Dunphy et al., 2006; Humphries et al., 
2009; Oh and Santy, 2010; Palacios and D'Souza-Schorey, 2003; Song et al., 1998). We thus 
decided to examine cell spreading kinetics in these MEFs. Cells were detached and suspended 
for 30min at 37
0
C after which they were plated on fibronectin-coated coverslips and allowed to 
spread at 37
0
C for indicated time points, before they were fixed with paraformaldehyde. To 
quantify cell size, coverslips were then immersed in PBS containing Alexa-coupled wheat germ 
agglutinin, a lectin which binds to sugar moieties at the cell surface. This was used to label the 
cell surface area. Fixed coverslips were then imaged directly (not mounted) using a live imaging 
chamber and acquisitions were thresholded in image-j to demarcate the cell area (Fig. 13a). 
Finally cell area was quantified and cell sizes were presented as a frequency distribution. Initial 
results show that there appeared to be no significant genotypic-specific cell-size differences in 
stable adherent cells (Fig. 13b). Cells were then plated on fibronectin coated coverslips and 





quantification as described above. Spreading on 5µg/ml fibronectin did not result in any 
significant difference in the spreading kinetics of Arf6 WT and KO MEFs (Fig. 13c).  
The spatial distribution of adhesion substrates on the extracellular space impacts intergrin 
clustering and cell spreading (Cavalcanti-Adam et al., 2006). Specifically, it was determined that 
cells plated on 110ηm inter-spaced integrin substrates, were able to spread much less efficiently 
than those plated on 58ηm spaced substrates. Furthermore in an independent study, it was 
determined that migration velocity was greatest when cells (PTK1 -a kidney epithelial cell line) 
migrated on an intermediate concentration of extracellular matrix substrate, corresponding to 
10µg/ml FN, whilst migration velocity was slower at either high (30µg/ml) or lower (5µg/ml) 
substrate concentration (Gupton and Waterman-Storer, 2006).  We reasoned therefore, that if 
Arf6 contributed to cell spreading dynamics, then the largest genotypic specific spreading 
difference would occur where WT spreading speed was least inhibited (for example at 10µg/ml). 
We therefore, tested whether matrix concentration influenced the spreading dynamics of Arf6 
WT and KO MEFs. As shown in (Fig. 13 c and d), genotype-specific differences were more 
pronounced in cells plated on 10µg/ml of fibronectin (Fig.13d) than in that plated on 5µg/ml 
(Fig.13c), particularly at the 20min time point (d) where spreading profiles were most offset 




, for WT and KO cells respectively-
compare to Fig. 13c, 20min time point). This result demonstrates that Arf6 ablation causes a 
kinetic delay in cell spreading when cells are spread at an intermediate substrate density. 
1.6.9 Arf6 mediates the transport of cholera toxin B-labeled vesicles to the plasma 
membrane during cell spreading: a link to the retromer complex 
 
Several studies have associated the trafficking of various integrins within lipid raft moieties 





gradient centrifugation experiments has found α2β1 integrin to be enriched in fractions 
containing detergent resistant membranes and glycosylphosphatidyl inositol anchored proteins, 
both of which are well-known components of cholesterol and sphingolipid-rich raft 
microdomains (Upla et al., 2004).  
These domains serve as signaling platforms in many different pathways including the integrin 
and epidermal growth factor receptor dependent signaling pathways and clearance from the cell 
surface results in the down regulation of signals mediated by these receptors (Simons and 
Toomre, 2000). 
In adherent cells rafts are endocytosed through clathrin and/or caveolin dependent as well as 
clathrin-caveolin independent pathways (Nabi and Le, 2003; Sabharanjak et al., 2002; Torgersen 
et al., 2001) that require dynamin, and are subsequently transported predominantly to the Golgi 
(Le and Nabi, 2003; Nichols, 2002), smooth endoplasmic reticulum (Pelkmans et al., 2001) and 
partially to the recycling endosomes (Ullrich et al., 1996).  However, when cells are detached, 
loss of integrin-mediated anchorage triggers the internalization and cell-surface clearance of rafts 
and their subsequent delivery, not to the typified Golgi compartments in adherent cells, but rather 
to recycling endosomes, in an actin and microtubule-dependent manner (Balasubramanian et al., 
2007; Gauthier et al., 2009). 
Subsequently, when cells are re-plated, integrin mediated cell-adhesion triggers the 
exocytosis of rafts from a recycling endosomal compartment and are returned to the plasma 
membrane in a microtubule dependent manner that is dependent on Arf6 (Balasubramanian et 
al., 2007)( see also Fig.14).  
These lipid rafts are enriched with the ganglioside GM1, which is commonly labeled with 





studies lead to the hypothesis that Arf6 mediates the recycling of endosomal-to-plasma 
membrane trafficking of lipid rafts and deletion of the gene results in reduced plasma membrane 
transfer of these rafts, and thus components of the spreading machinery that are transported to 
the plasma membrane in these rafts. Consistent with this we found extensive co-localization 
between Arf6-eGFP and cholera toxin-B labeled vesicles in spreading cells (Fig. 14a lower 
panel). In this experiment cells were transfected for 24 hours with Arf6-eGFP, and subsequently 
pulsed for 20min using Alexa-555- labeled cholera toxin-B, before being detached and re-
suspended for 30min. Following this, cells were then plated on fibronectin coated coverslips and 
allowed to spread for 20min before fixing. As indicated cholera toxin-B localizes extensively in 
a densely aggregated perinuclear region (presumably the recycling endosomes) as well as in 
punctate vesicular structures near the cell periphery (Fig. 14a lower panel). Another prediction 
from this hypothesis (stated above) would be that the surface emergence of lipid rafts would be 
reduced in the Arf6 KO MEFs upon cell spreading. In order to test this, WT and KO MEFs were 
detached and subsequently spread on 10µg/ml fibronectin for 20min (where the maximum 
genotype specific difference in cell size was seen) at which point spreading was arrested by 
incubation in ice-cold PBS for 15min. Cells were then subsequently incubated with a biotin-
labeled cholera toxin-B probe (to label surface rafts) for 15min after which cells were washed (to 
remove unbound surface probe) and lysed. Extracts were then probed with streptavidin-HRP to 
report the surface levels of cholera toxin-B. Results show that surface levels of cholera toxin-B 
was reduced by 30% in cells deleted for Arf6 (Fig. 14b). This is consistent with the overall 
hypothesis that AFF6 facilitates the trafficking of lipid rafts towards the plasma membrane 





We then resorted to determine other components of this Arf6 regulated machinery by 
conducting a small screen to identify proteins that localized to Arf6 and cholera toxin-B labeled 
vesicles (see: Fig. 14a). In this screen, as before cells were pulsed for 20min with Alexa-555- 
labeled cholera toxin-B, before being detached and re-suspended for 30min. Following this, cells 
were then plated on fibronectin coated coverslips and allowed to spread for 20min before fixing. 
Cells were then stained with various probes to identify which candidate proteins localized to 
cholera toxin-B labeled vesicles. Candidates tested included several focal adhesion enriched 
proteins including paxillin, vinculin, and FAK, none of which showed any significant co-
localization with cholera toxin-B labeled vesicles. In a surprising result however, we found that 
cholera toxin-B probe, co-localized with VPS35 (Fig. 15a), a core component of the retromer 
complex (Fig. 16). In complimentary findings, Arf6-eGFP was similarly found to co-localize 
with VPS35 labeled vesicular structures (Fig. 15b).  
1.6.10 An overview of the retromer complex 
 
Endosomal-to-Golgi transport of cargo and receptors is critical to various physiological 
processes, such as in lysosomal maintenance (Arighi et al., 2004) and development (Eaton, 
2008). The primary role of the retromer complex is to mediate trafficking in this pathway (Cullen 
and Korswagen, 2012). This complex, mediates the trafficking/retrieval of various 
transmembrane receptors like the cation-independent mannose 6-phosphate receptor (Arighi et 
al., 2004), and the Wnt receptor Wntless (Harterink et al., 2011). An Arf6 regulated endosomal-
to-plasma membrane function, ascribed to this complex would be a novel finding.  
Retromer was first discovered in baker’s yeast (Saccharomyces cerevisiae) in isolation of 
VPS (Vacuolar Protein Sorting) mutants unable to properly traffic proteins to the vacuole (yeast 





heteropentameric complex that coordinates cargo sorting with membrane deformation and 
fission. The sorting capacity is by way of the “cargo selective adaptor” subunit of the complex 
(also termed the “retromer core”) which consists of :Vps35p, Vps26p and Vps29p. Its 
“membrane deforming” subunit, on the other hand consists of Vps5p and Vps17p. 
There is at least one orthologue for each of the retromer cargo selective adaptor components 
(Vps35p, vps26p and Vps29p) in mammals with sequence identities in that range from 30-42% 
(Robinson et al., 2012). In addition, the membrane-deforming components (Vps5p and Vps17p), 
has as mammalian orthologs, sorting nexins (SNXs 1 and 2) for Vps5p and SNX 5 and 6 for 
(Vps17p) respectively (Cullen and Korswagen, 2012).  
1.6.10.1 The assembly of the retromer complex  
 
The cargo selective adaptor core component, VPS35, forms an α‑helical solenoid onto which the 
other core components (VPS26 and VPS29) associate at either distal end (Cullen and 
Korswagen, 2012). Complexed, to this trimmer core are components of the membrane deforming 
sub-complex which include SNX proteins, 1,2,5 and 6 (Wassmer et al., 2007) . The SNX 
proteins assembly into heterodimers is based on one simple rule; one Vps5 equivalent (Vps5, 
SNX1 or SNX2) dimerizes with one Vps17 equivalent (Vps17, SNX5 or SNX6) (van Weering et 
al., 2010). SNX proteins are members of the SNX-BAR subfamily containing a membrane 
curvature-sensing BAR (Bin/amphiphysin/Rvs) domain, as well as a phosphoinositide-binding 
PX (phox homology) domain. For BAR domains, dimerization confers the ability to sense 
membrane curvature and certain BAR’s, in addition to curvature-sensing, are able to induce 





1.6.11 A role for Arf6 and retromer in membrane trafficking of cholera toxin-B labeled 
vesicles to the plasma membrane during cell spreading 
 
We found that the cargo selective adaptor core component (VPS29) strongly co-localizes with 
cholera toxin-B (raft)-labeled plasma membrane bound vesicles during cell-spreading (Fig. 17). 
As mentioned before Arf6 regulates the exocytosis of cholera toxin-B labeled vesicles to the cell 
surface, as surface cholera toxin-B levels are reduced in KO MEFs during spreading. In addition, 
a dominant negative allele of Arf6 strongly inhibits (~75% of control) the emergence of surface 
levels of this probe during cell spreading (Balasubramanian et al., 2007). That VPS29 co-
localizes to cholera toxin-B labeled plasma membrane bound vesicles, suggests a new and un-
defined role for retromer in an Arf6 regulated recycling endosome-to-plasma membrane 
vesicular trafficking pathway. Such an Arf6 regulated pathway has been described to mediate the 
transport of cargo lacking clathrin/AP2 cytoplasmic targeting sequences, such as IL-2 receptor 
alpha subunit Tac to the plasma membrane (Radhakrishna and Donaldson, 1997). 
Our findings (VPS29- cholera toxin-B co-localization) raise important questions. For one, the 
VPS26–VPS29–VPS35 cargo selective adaptor, lacks membrane-binding motifs but has been 
reported to interact with endosomes via the small GTPase Rab7-GTP (important in the late 
endocytic pathway) which acts to restrict the diffusion of the cargo; favoring a cargo-bound 
nucleation complex (Cullen and Korswagen, 2012). It is tempting therefore, to suggest that the 
small GTPase Rab11 (associated with secretory/recycling pathway), may be a functional 
substitute to Rab7 in the mediating the retromer cargo selective core recruitment, towards an 
Arf6-regulated endosome-to-plasma membrane recycling pathway. 
The recruitment of the cargo selective core to endosomal membrane is also governed by 





core) to specific phosphatidylinositol derivatives (Koharudin et al., 2009). Many SNX proteins, 
contain, in addition to a BAR domain (mentioned above), a phosphoinositide-binding phox 
homology (PX) domain, which functions in, sensing high-curvature subdomains of the PI3P 
/PI(3,5)P2 -enriched endosomes (Cullen and Korswagen, 2012). Thus the binding of the SNX 
proteins to different phosphoinositides, (which in turn are differentially enriched sub-cellularly, 
(Di Paolo and De Camilli, 2006) provides a regulatory layer for targeted membrane recruitment 
of retromer complex. 
We found that cell spreading is marked by a substantial increase in the levels of PI3P as 
measured by HPLC (Fig. 18 a). Furthermore, we have confirmed by means of the PI3P 
biosensor, GFP-2xFYVE that some of this spreading-relevant PI3P, is associated with cholera 
toxin-B labeled vesicles that are exocytosed to the plasma membrane during cell spreading (Fig. 
18b). Co-incidentally, SNX1-GFP was also found to localize to this biosensor (Vermeer et al., 
2006). Taken together, these results suggest that a PI3P-binding SNX (which may include SNX1 
or 2, but not SNX 5 (Koharudin et al., 2009) facilitates the recruitment of retromer to cholera 
toxin-B labeled vesicles in an Arf6 regulated recycling pathway to the plasma membrane. This, if 
true, will be the first defined role for retromer in this capacity. 
1.7 CONCLUDING REMARKS AND FUTURE DIRECTIONS  
 
The small GTPase Arf6 functions in many steps along the vesicular trafficking pathway, and 
links the actin cytoskeleton to several aspects of membrane trafficking. In addition to its role in 
the trafficking of various receptors including the transferrin receptor discussed above, we have 
unearthed a previously unreported link between Arf6 and retromer, a complex established in 





molecular characteristics of this relationship and its physiological significance in cell migration. 
Currently experiments are underway to determine whether or not Arf6 directly interacts with the 
retromer complex proteins (in immunoprecipitation assays) and whether the spreading defects 
determined for Arf6 in our system, is also apparent in retromer-knock down paradigms. 
Specifically cell spreading kinetics will be assayed in Arf6 WT and KO MEFs depleted (via 
siRNA) for retromer. A functional relationship between retromer and Arf6 during cell spreading 
would imply that depletion of retromer in the Arf6 KO MEFs would not result in an additive 
inhibition effect in cell spreading kinetics in these KO MEFs.  We will also examine whether 
retromer depletion, similar to Arf6 depletion, results in a reduction in the trafficking of raft 
membranes to the plasma membrane.  
A recent study employing the use of dominant negative Arf6 alleles and siRNA mediated 
depletion of Arf6 was found to mediate the adhesion-dependent trafficking of lipid rafts to the 
plasma membrane during cell spreading. We have confirmed these results using a genetic 
approach where MEFs can be acutely induced for Arf6 deletion in culture and extended these 
results to include a role for retromer, in functioning as part of the machinery mediating this 
trafficking. However there are many more questions to answer including, determining the 
molecular motors that drive the centripetal translocation of these vesicles to the plasma 
membrane during this process, and others to determine the respective GEFs and GAPs that 
interact with Arf6 during this trafficking event. Finally we will test whether the spreading delay 
seen the KO MEFs translates into migration defects in a variety of assays. Our preliminary 
results (of a wound healing assay) suggest that cell migration is not profoundly affected in the 





 In this discussion above, we have primarily focused on the vesicular trafficking aspect of 
Arf6, but its effect is not just limited to vesicular trafficking and neither to cytoskeletal re-
organization for that matter. Indeed membrane trafficking drives migration in cells and when 
trafficking programs are dysregulated, diseases and pathological states emerge. Arf6 activity for 
example is generally up-regulated in tumor cells and has also been linked to their invasive 
properties in vivo (Muralidharan-Chari et al., 2009b; Premont and Schmalzigaug, 2009). Tumors 
however, are tissue-specific diseases and metastatic profiles and phenotypes may vary between 
tumors (Sabe et al., 2009).  Thus defining particular metastatic pathways activated in different 
kinds of tumors and cancers, may be an endeavor of the future. In vitro and cell biology studies 
have longtime furnished a wealth of information concerning various pathways, regulators and 
effector molecules that surround Arf6 during the execution of such pathogenic and invasive 
programs. Thus a critical effort for future work would be towards aims in determining the 
physiological significance of such programs at the whole-animal level. It would be of great 
interest therefore to launch efforts into the generation and study of mice bearing systematic 
combinatorial deletions of Arf6 with the genes of other proteins that are known to participate in 












2 PHOSPHOLIPASE D  
2.1 Phospholipase D History 
 
Phospholipase D (PLD) activity was first discovered in the 1940’s by Hanahan and Chaikoff, 
who described a phospholipid-specific phosphodiesterase activity in carrot and soy bean extracts, 
that was found to be able to liberate choline and phosphatidic acid (PA) form commercially 
prepared phospholipids (Hanahan and Chaikoff, 1947a, b). Later it was determined that this PLD 
enzymatic activity could catalyze a transphosphatidylation reaction, in the presence of primary 
alcohols, which served as acceptors for the formation of corresponding alcohol derived lipids 
(Dawson, 1967). These experiments were inspired from observations at a conference (9th 
International Conference on the Biochemistry of Lipids) where a group of scientists (Noordwijk 
and  Zee, 1965), spoke of findings where they identified alcohol lipid-derivatives, 
(phosphatidylethanol and phosphatidylmethanol) being formed when plant tissues (containing 
PLD) were extracted with cold alcohol (Dawson, 1967).  Then, this unique 
transphosphatidylation capacity of PLD presented a utility for chemists at the time, as the 
enzyme could be utilized as a chemical synthesizer in the generation of lipids species, partially 
towards industrial ends (Mansfeld and Ulbrich-Hofmann, 2009; Ulbrich-Hofmann et al., 2005).  
Today, this transphosphatidylation reaction (described later in more detail) has now 
become a hallmark property of PLD enzymes where primary alcohols are preferred instead of 
water as substrates during enzymatic activity, favoring transphosphatidylation over hydrolysis 
respectively (Fig. 19).  
In these earlier applications, the PLD activity was derived from crude or partially purified 
plant extracts such as white cabbage (Dawson, 1967; Eibl and Kovatchev, 1981; Mansfeld and 





progression of PLD research, but without DNA and proteins sequences, the elucidation of the 
molecular nature of PLD was hindered. However, purification and isolation of particular PLD 
enzymes was difficult, as they proved to be very sensitive enzymes and resistant to purification, 
particularly in the case of mammalian PLD’s (Okamura and Yamashita, 1994).  
This obstacle was overcome when a cDNA clone encoding  a PLD enzyme later termed PLDα,  
was successfully purified from two independent laboratories from cabbage (Brassica oleracea) 
(Abousalham et al., 1993) and castor bean endosperm (Ricinus communis) (Wang et al., 1993). 
Sequence analysis of the N-terminal peptide from these purified proteins revealed that they 
shared a nearly identical 10-amino acid sequence, which was later used to isolate a full-length 
cDNA clone encoding a 92-kDA protein from endosperm cDNA library (Wang et al., 1994). 
This marked the first eukaryotic phosphatidylcholine (a phospholipid bearing choline as a 
headgroup)-specific PLD to be cloned.  
This cDNA when expressed in Escherichia coli possessed  both hydrolytic and 
transphosphatidylating PLD activity with phosphatidylcholine as a substrate and this 
demonstrated to the investigators that these two reactions  were mediated by the same enzyme 
(Wang et al., 1994). Similar efforts were subsequently conducted to isolate clones from rice, 
maize, tomato and others (Cha et al., 1998; Pappan and Wang, 1999; Ueki et al., 1995).   
The then newly found availability of PLD sequences, sparked efforts through sequence 
homology, that further identified a vast number of plant PLD enzymes (reviewed in (Wang, 
2000). In addition, discoveries of new genes were made across a diverse number of other 
organisms. Here we will explore discoveries made in bacteria, yeast, as well as a relatively recent 
report, of a PLD enzyme located on the surface on mitochondria. Finally we will discuss findings 





2.1.1 PLD enzymes in bacteria 
 
PLD-like sequences have been identified and characterized in many species of bacteria, 
including  Saccharomyces cerevisiae, Escherichia coli, Salmonella  typhimurium, Proteus 
vulgaris, Pseudomonase aeruginosa, Bacillus subtilis, and Streptoverticillium cinnamoneum 
(Cole and Proulx, 1975; Hammond et al., 1995; Liscovitch et al., 2000). Some of these PLD-like 
genes, are thought to encode endonucleases, as is the case with the Salmonella typhimurium  Nuc 
enzyme, which represents a prokaryotic branch of the PLD superfamily, that uses 
phosphodiesterase activity to cleave the backbone of DNA (this bond is analogous to the 
phosphodiester bond in phospholipids (Stuckey and Dixon, 1999; Su et al., 2009a). 
Generally, bacterial enzymes have broader substrate specificities than plant, yeast and 
mammalian enzymes, and can uniquely hydrolyze substrates like lysoPC and sphingomyelin 
lipids (Hynes, 2002). They can function at an alkaline pH optimum (pH 8-9) which is generally 
unlike the typical PLD enzymes purified from other sources  which are in turn typically most 
active at neutral pH (Morris et al., 1997).    
Deletion studies in pathogenic bacteria suggest that PLD may have roles in viability and 
pathogenesis (Cross et al., 1996) however the mediating pathways for these roles are unclear. It 
is also suggested elsewhere that the bacterial enzymes through catalyzing the production of the 
lipid mediator lysophosphatidic acid (LPA) may induce pathological states which include local 
inflammation, vascular permeability and platelet aggregation (van Dijk et al., 1998).    






Recently, a blast search for additional members of the PLD superfamily uncovered a novel 
interesting PLD occurring on mitochondrial surfaces which was later named MitoPLD (Mansfeld 
and Ulbrich-Hofmann, 2009).  
The catalytic motifs in this enzyme (named the HKD motif denoting to highly conserved 
residues in the catalytic HxKxxxxD/E motif sequence of this family of enzymes-discussed later) 
was dissimilar to the that in the canonical previously described PLD’s.  
Virtually all prokaryotic and eukaryotic PLDs encode two half-HKD motifs that fold together to 
form substrate pocket which functions as a single catalytic unit during enzymatic activity 
(Hammond et al., 1995; Uesugi and Hatanaka, 2009).    
Unlike the classical PLD family members however, sequence analysis has revealed that 
MitoPLD is evolutionary, a very divergent PLD superfamily member, containing only one half-
catalytic HKD site which requires the enzyme to dimerize to create an active enzymatic complex 
(Choi et al., 2006b).  This feature makes MitoPLD more similar to the prokaryotic enzyme Nuc 
(mentioned above) (Stuckey and Dixon, 1999), and the bacterial enzyme cardiolipin synthase 
(Koonin, 1996; Ponting and Kerr, 1996). This lipid, cardiolipin (the MitoPLD substrate) is found 
almost exclusively on mitochondrial membrane and on the membrane of most bacteria. 
Unlike the prokaryotic Nuc however, the major biological process demonstrated for MitoPLD 
however was neither endonuclease activity nor cardiolipin (CL) synthesizing activity but rather 
to catalyse the reversal of CL synthase activity; hydrolyzing cardiolipin to generate PA (Huang 
and Frohman, 2009). 
Bioinformatic approaches first revealed that MitoPLD contained a predicted N-terminal 
mitochondrial leader import sequence, and was found to localize to the surface of mitochondria 





MitoPLD to be an outer surface membrane protein anchored to mitochondria via its amino-
terminus, with the catalytic-C-terminus protruding into the cytosol-as one would expect for a 
monomer carrying half the active site (Choi et al., 2006b).     
It is reported that about 10-20% of the total mitochondrial cardiolipin (the determined substrate 
for MitoPLD) is also found on the mitochondrial outer membrane surface where MitoPLD 
localizes (Hovius et al., 1993; Liu et al., 2003).  Furthermore as mentioned above, MitoPLD uses 
cardiolipin as a substrate to generate PA, a fusogenic lipid that underlies different fusion/fission 
processes (Fig. 21). Taken together this data supports an overall model where the MitoPLD 
catalytic unit facing away from the mitochondrial membrane surface, would dimerize to form an 
active catalytic pocket producing PA (through the metabolism of cardiolipin) on opposed sides 
of mitochondrial surfaces which would in turn facilitate mitochondrial fusion (Roth, 2008). In 
support of this theory, MitoPLD dimerization has been demonstrated in vitro (Choi et al., 
2006b). 
Consistent with a role for MitoPLD in fusion, over expression of the enzyme caused 
mitochondria to aggregate (Choi et al., 2006b). On the other hand negative disruption of 
MitoPLD by siRNA or by over expression of the catalytically dead enzyme resulted in 
fragmented mitochondira (Choi et al., 2006b; Roth, 2008). One of the effects of generating PA at 
the surface of mitochondria is to recruit a PA phosphatase called lipin1 (Reue and Zhang, 2008). 
This enzyme converts PA into diacylglycerol an important second messenger with numerous 
signaling functions in the cell (Huang et al., 2011). Lipin1 overexpression (which also negatively 
regulates PA levels by converting it to diacylglycerol) had an expected similar fragmentation 
phenotype, as seen when MitoPLD was negative regulated, reinforcing the fusogenic role of for 





regulation of PA pools at the mitochondrial surface, may translate in increased pool of 
diacylglycerol on account of lipin activity. As diacylglycerol is a second messenger, its 
production may also lead to the initiation of a cascade of downstream signaling events which 
may affect fission as well as energy production (Peng and Frohman, 2012). Taken together this 
data suggest that PA and diacylglycerol regulate mitochondrial dynamics by playing reciprocal 
roles that facilitate fusion/fission on the on the mitochondrial membrane surface. (Peng and 
Frohman, 2012). It has been postulated that the that balance of mitochondrial fusion/fission may 
impinge on its ability to generate energy (Huang and Frohman, 2009) and defects in 
fusion/fission has been linked to neurodegenerative disease and apoptosis (Chen and Chan, 2009; 
Wasilewski and Scorrano, 2009). 
2.1.3 PLD in Yeast 
 
A glucose related PLD activity had been implicated in the ability of yeast to repress 
mitochondria generation (mitochondriogenesis) as early as in the 1970’s (Dharmalingam and 
Jayaraman, 1971; Grossman et al., 1973).  Subsequently sequences made available through the 
chromosome XI sequencing project (Dujon et al., 1994) identified a yeast open reading frame 
(designated as YKR031c which would be later named SPO14) bearing sequences that matched 
the predicted protein sequence of a PLD gene (PLDα ) identified in plant (Ricinus communis) 
(Wang et al., 1994). This prompted Rose and colleagues to investigate whether or not SPO14 
encoded a functional enzyme. They went on to show that SPO14 when expressed in insect cells 
(Hi5) exhibited substantial phosphatatidylcholine-specific membrane-associated PLD activity 
(Rose et al., 1995). Spo14 exhibits similarity to plant PLDα over a central 400-amino-acid 
region. It possesses a 5049-bp open reading frame, and encodes a protein with a predicted 





(together with other fungal PLDs from Candida albicans and Schizosaccharomyces pombe) the 
largest PLD form so far discovered (Liscovitch et al., 2000)-despite that fact that the catalytic 
core, consisting of 436 residues (aa 694-1129), is amongst the most compact in eukaryotic PLDs 
(Liscovitch et al., 2000). The gene was later found to exhibit Ca
2+
-independent PLD activity, and 
was activated by PI(4,5)P2 (Rose et al., 1995), but was unresponsive to Arf (Rudge et al., 
1998a). This gene is not an essential component of membrane traffic during vegetative growth, 
as mutant yeast are viable under these conditions (Liscovitch et al., 2000). However, during 
starvation, Spo14p is required to form prospore membranes the formation of which requires 
rerouting of exocytic post-Golgi derived vesicles to developing spores. 
During sporulation, meiotic development culminates to the production of spores, where 
yeast chromosomes are duplicated and segregated into four haploid nuclei sets, which are 
subsequently enclosed by a membrane bilayer in the process of being packaged into spores. As 
indicated before, post-Golgi and endocytic vesicles are re-routed to a modified spindle pole body 
(the equivalent of the mammalian centrosome) where they fuse and generate the lipid bilayer 
which will eventually engulf and encapsulate the haploid nuclei (Mendonsa and Engebrecht, 
2009).  
The involvement of Spo14 in this process has been shown in sporulation-induced cells, where 
GFP-Spo14p (largely found in the cytoplasm) was found to re-distribute to a fluorescent foci that 
co-localized with spindle pole body markers. At later times, this probe expanded to encircle the 
mature spore membrane (Rudge et al., 1998b).  Furthermore, neither a catalytically dead mutant 
nor an N-terminally-truncated Spo14p mutant which fails to localize to prospore membranes 
(though catalytically active) is able to rescue sporulation defects in spo14/pld1 disruptant strains, 





Spo14p is translocated to spore membranes, where it catalyses phosphatidylcholine to PA 
conversion using PI(4,5)P2 as a co-factor (Liscovitch et al., 2000).  
Subsequently, electron microscopy and cellular fractionation studies demonstrated that in the 
absence of functional spo14, precursor vesicles are docked on modified spindle polar bodies, an 
observation similar to what was observed when Sso1, a syntaxin SNARE was disrupted. Thus it 
was concluded from these series of studies that PLD functions at a vesicle fusion step of 
membrane trafficking during pro-spore membrane formation (Nakanishi et al., 2006).  
In other work, SPO14 has been linked to the secretion of Acl1 (a secreted Acyl-CoA binding 
protein that lacks a signal sequence and does not transit through the secretory pathway) in an 
unconventional secretion pathway in Pichia pastoris (Manjithaya and Subramani, 2010). Since 
the discovery of SPO14, PLD genes have also be characterized in other yeast species, including 
Schizosacharomyces pombe, and Candida albicans (Rudge and Engebrecht, 1999). The 
remarkable gene conservation both at the sequence and functional levels between yeast PLD 
genes and mammalian genes has been an impetus for discoveries in mammalian systems.  
2.1.4 PLD enzymes in mammals  
 
Mammalian PLD activity was demonstrated as early as 1975 when Saito and Kanfer reported 
phosphatidyclonline specific PLD activity in rat brain extracts, where choline, and PA was 
released in vitro (Saito and Kanfer, 1975). 
Subsequently, using the then established SPO14 sequence (described above), Hammond et al. 
identified mammalian expressed sequence tag (EST) clones of homologous proteins from a HeLa 
cDNA library. This investigation unearthed, a large open reading frame encoding a 1072-amino 
acid protein which was named human PLD1 (hPLD1)-henceforth referred to as PLD1 





Expression studies in insect (sf9) and mammalian (Cos-7) cells revealed that PLD1 catalyzed 
both hydrolysis and transphosphatidylation reactions with water or alcohol as substrates 
respectively, when presented with phosphatidylcholine (Hammond et al., 1995). The enzyme 
activity was found to be stimulated (11-fold) by PI(4,5)P2, inhibited by oleate, and activated by 
GTPγS-loaded Arf1(Hammond et al., 1995). Subsequently, Hammond and colleagues in aims to 
examine regulation of PLD1 mRNA levels in HeLa noticed a smaller PLD transcript 
corresponding to an altered form of PLD1 in which 114 nucleotides were missing. This transcript 
lacked 43 amino acids within the “loop” region between the catalytic domains and necessitated 
the re-designation of the original enzyme as PLD1a and the splice variant PLD1b (Hammond et 
al., 1997; Katayama et al., 1998).  Both enzymes had very similar properties being sensitive to 
PI(4,5)P2, PI(3,4,5)P3, Mg
2+
, GTPγS-loaded Arf1, protein kinase C (PKC), and to a lesser extent 
Rho family monomeric GTP-binding proteins (Hammond et al., 1997).  
PLD1 cDNA coding region was used as a probe to screen a mouse embryonic library, and a 
cDNA ending a 932-amino-acid proteins was identified, which showed regions of homology to 
PLD1 throughout its length but particularly within the central catalytic core (Colley et al., 
1997b). Less similarity was observed between the amino termini which is not required for 
catalysis (Colley et al., 1997b). In addition, this gene did not encode a PLD1-like “loop” region, 
which was found in PLD1 and was therefore deemed to be distinct and was named PLD2 
(Hammond et al., 1997).  
PLD 1 (human) and PLD2 (mouse) share about 51% identity and differ in their basal activity and 
regulatory interactions (Colley et al., 1997b). It is presumed that gene duplication event that 





nematode, and drosophila all have only one PLD gene, which in the case of drosophila, is more 
similar to PLD1(McDermott et al., 2004; Ponting and Kerr, 1996).  
The catalytic and regulatory properties of PLD1 and 2 are significantly different from each other 
(Table 5). The basal activity of PLD2 is 1000-fold higher than that of PLD1(which appears to 
adopt an inactive confirmation until bound by activators (McDermott et al., 2004; Singer et al., 
1997),  yet still 50-fold higher, when PLD1 is stimulated by Arf (Morris et al., 1997). The 
enzyme (PLD2) itself, appeared unresponsive to stimulation by Rho family GTP-binding 
proteins, PKC and Arf (McDermott et al., 2004), hence it is believed that in the latter (Arf-
stimulated context), it is mostly PLD1 that contributes to the total PLD activity (Brown et al., 
1993; Cockcroft et al., 1994). PLD2 however did require PI(4,5)P2, and its activity was elevated 
by fatty acids (Colley et al., 1997b). 
PLD 1 and 2 comprise the classical mammalian PLD enzyme family, and since their isolation 
and cloning, PLD activity has been found in most mammalian cell types with few exceptions in 
leukocytes and a few lymphocytes lines (Bradshaw et al., 1996; Kinsky et al., 1989).  
Altogether, the aforementioned PLD genes, along with others identified from diverse origins 
ranging from human, viral to murine species (McDermott et al., 2004), comprise an extended 
superfamily of PLD genes, unified by a most important coding feature; the HKD catalytic motifs 
which is essential for catalysis (described in further detail below).  
 
2.2 PLD STRUCTURE 
 
The discovery and exploration of PLD genes in the plant and yeast systems, made it evident that 





of discovery in others systems and species including Caenorhabditis elegans, Drosophila 
melanogaster and humans. PLD enzymes exhibit a characteristic “modular” structure where a 
common catalytic core domain is flanked by regulatory sequences (McDermott et al., 2004).  
2.2.1 The PLD HKD motifs and enzyme catalysis 
 
The catalytic core of eukaryotic PLD1 and PLD2 enzymes consist of four domains 1-IV (Fig. 22) 
(Kanaho et al., 2009; McDermott et al., 2004) amongst which II and IV are especially highly 
conserved in various organisms, as they contain the invariant charged and highly conserved 
HxKx4–Dx6GSxN motif (HKD motif) which is necessary for catalysis (Kolesnikov et al., 2012; 
McDermott et al., 2004). Evidence suggests that the duplicated HKD motifs cannot function 
independently of each other and mutational studies that substitute residues in either HKD motif 
inactivate the enzymes (Sung et al., 1997; Xie et al., 2000). Much of the evidence supporting the 
current prevailing model for a mode of PLD catalysis was spurred from the classical experiments 
of Stanacev and colleagues who proposed that catalysis occurred in a two-step  “ping ponged” 
mechanism, where  the PLD substrate was successively attacked by the imidazole residues of the 
Histidines in each HKD motifs of the enzyme  (Fig. 20) (Stanacev and Stuhne-Sekalec, 1970). In 
this model, the first half of the reaction proceeds where one histidine acts as an nucleophile and 
attacks a phosphate diester bond in the substrate, forming a (phospho-enzyme) intermediate 
molecule, whilst the histidine of the other motif acts as a general acid protonating the leaving 
group (McDermott et al., 2004). Evidence of the existence of such an intermediate molecule has 
been presented by Gottlin and coleagues examining the reaction catalyzed using the Salmonella 
typhimurium endonuclease Nuc, a member of the HKD super family which possesses only a 
single HKD motif, but dimerizes to perform catalysis (mentioned above) (Gottlin et al., 1998; 





enzyme) intermediate thus completing the catalytic reaction (Gottlin et al., 1998; Orth et al., 
2010). Consistent with this model, a necessary role for the Histidines was demonstrated when 
Iwaski et al showed that mutations in histidine residues of either HKD motif relinquished 
binding to a fluorescently labeled substrate NBD-PtdCho (Iwasaki et al., 1999). Several sources 
of evidence suggest that the lysine and aspartic acid residues of the HKD motifs are also 
important for catalysis as mutations of these residues also abolish activity and are in-fact 
commonly employed as dominant negative alleles in cells (Iwasaki et al., 1999; Kanaho et al., 
2009; Secundo et al., 1996). The lysine residue for example was shown to be important for 
maintaining charge stabilization in the enzyme intermediate, whilst the aspartic acid residue, in 
intramolecular interactions (Leiros et al., 2000; Stuckey and Dixon, 1999). 
2.2.2 Other PLD domain structures  
2.2.2.1 Region1  
 
Domain 1, also a domain found only in PLD members that exhibit PLD activity, contain some 
regions that are critical for enzymatic activity whist other regions appear to be dispensable 
(Stanacev and Stuhne-Sekalec, 1970). Although deletion of this region appears neither to affect 
the enzyme’s activity, nor its dependence on PI(4,5)P2, a leucine-405 to aspartic acid substitution 
abolished enzymatic activity, whilst a glycine-412 to alanine or glutamic acid reduced activity to 
85% and 87% respectively (Sung et al., 1999a). 
2.2.2.2 Domain III 
 
The IYIENQFF sequence in Domain III (Fig. 22) is a conserved sequence  found only in 
members that exhibit a bona-fide PLD activity, and has been demonstrated through mutagenesis 





tyrosine to serine mutation in the IYIENQFF motif of PLD1 resulted in 15% activity, whilst 
mutation to cysteine or to isoleucine gave 40% and 45% of activity respectively (McDermott et 
al., 2004). Domain III is enriched in aromatic residues, a characteristic that has been shown 
elsewhere to be a critical for choline binding (to the acetylcholine receptor) (Gilson et al., 1994; 
Harel et al., 1993); thus it has been suggested that this domain may play a role in increasing 
substrate specificity in mediating binding to phosphatidylcholine (Frohman and Morris, 1999). 
Finally, this domain has also been suggested to recruit PLD to caveolin (Okamoto et al., 1998).    
2.2.2.3 PX domain:  
 
PX (phox) domains are protein moieties that mediate protein and lipid binding of a diverse range 
of signaling molecules. These domains have been reported to bind a variety of phosphoinositides 
including PI3P, PI(3,4)P2, PI(4,5)P2, PI(3,5)P2, and PI(3,4,5)P2 (Xu et al., 2001), as well as 
mediate kinase and SH3-biding (Ponting, 1996). Human yeast and nematode PLDs all contain 
PX domains in their N-termini (Liscovitch et al., 2000; Ponting and Kerr, 1996). Recent work 
suggests that the PX domain of PLD1 may mediate the targeting of the enzyme to endocytic 
vesicles by binding to the phosphoinositide PI3P (Hodgkin et al., 2000). However other analysis 
suggests that this may be dispensable for activity as in vitro (Manifava et al., 1999).   
2.2.2.4 PH domain 
 
The PLD PH domain, was demonstrated in surface plasmon resonance studies, to bind 
specifically to PI(4,5)P2, and it is important for PLD localization and regulation (Hodgkin et al., 
2000). However the domain appears to be dispensable for enzymatic activity, as removal of the 





stimulated activity, suggesting that it may have an actual negative effect on enzyme activity 
(Sung et al., 1999a; Sung et al., 1999b).  
2.2.2.5 The IGSANIN motif 
 
A serine-911 to alanine (S911A) substitution within PLD1 was demonstrated to abolish activity 
(Manifava et al., 1999). This residue lies within region of the gene known as the IGSANIN 
motif. Mutation of this residue altered the localization of the protein which was partially (but not 
entirely) redistributed to the cytosol and was furthermore found not able to be palmytoylated. 
This suggested that catalytic activity and membrane binding are linked where this residue is 
concerned.  
2.2.2.6 Loop sequences 
 
PLD1 encodes a 100-150 amino acid loop region at the center of the protein between regions I 
and II, that is absent in PLD2 or in most lower organisms, with the exception of nematode and 
Drosophila-which contain two extra loop regions (Colley et al., 1997b; Hammond et al., 1995). 
This loop appears to be dispensable and highly divergent amongst closely related species. It 
undergoes alternative splicing which does not appear to significantly affect its activity, 
localization or regulation (Colley et al., 1997b; Hammond et al., 1995). Furthermore, inserting 
this region into PLD2 has only modest changes in activity (Hammond et al., 1997; Sung et al., 
1999a), however, deleting this region from PLD1 incurred a three-fold increase in its activity 
indicating that it may play a negative role on the activity of the enzyme (Sung et al., 1999a).  






The N-termini of PLD’s are poorly conserved across a wide variety of species, and accordingly 
appears to be tolerant of genetic modifications such as fusions to peptides and tags, without 
resultant significant consequence to changes in enzymatic activity localization and regulation. In 
fact, removal of the N-terminal 325 amino acids of PLD1, and n-terminal deletion in PLD2 both 
appeared to enhance sensitivity to Arf (Sung et al., 1999a; Sung et al., 1999b). Elsewhere, it has 
also been reported that the N-terminus of PLD1 is also critical for stimulation by PKC (discussed 
below) (Zhang et al., 1999).    
2.2.2.8 C-terminus 
 
In contrast to the N-teminus, the c-terminus is intolerant of such genetic modifications, and is 
relatively well conserved amongst higher eurkaryotes (Sung et al., 1999a; Sung et al., 1999b). 
Modification of as little as the c-terminal threonine or the addition of a single alanine attenuates 
enzymatic activity (Liu et al., 2001). Furthermore, the enzyme may be regulated by effectors at 
this local as studies show that at least Rho interacts with PLD1 at the c-teminus (Liu et al., 
2001). 
2.3 PLD EXPRESSION IN TISSUES AND CELLS 
2.3.1 PLD expression in tissues 
 
Biochemical assessment of PLD activity has been examined in a multitude of tissues and cell 
lines for many years by exploiting the unique transphosphatidylation capacity of these enzymes. 
The subsequent cloning of the PLD 1 and 2 enzymes spurred a wealth of (often contradictory) 
information regarding their distribution in tissues and cell types (reviewed in (Meier et al., 1999).  
Owing to a general lack of availability of high-affinity antibody to PLD isoforms, these studies 





mRNA levels faithfully reflect the expression levels and distribution of endogenous protein 
(Meier et al., 1999). Indeed different investigators report somewhat different results, using 
tissues of the same species. Some reasons for these discrepancies may be due to the 
oligonucleotide probe used or the experimental technique used and these confounding factors 
may make it difficult to draw concise reproducible conclusions (Meier et al., 1999).  
Nevertheless, the general consensus amongst many of these studies is that PLD isoforms are 
expressed in almost all tissue and cell types and across a variety of species including rat, mouse 
and human (reviewed in (Meier et al., 1999) with few exceptions in renal tissue, (where PLD1 
expression was undetected (Zhao et al., 2000) and also in peripheral leukocytes and some 
lymphocyte cell lines (Bradshaw et al., 1996; Kinsky et al., 1989). 
2.3.2 PLD expression in cells 
 
As with the mRNA based studies, the localization of PLD1/2 enzymes at the subcellular level are 
a subject of mixed reports and varying descriptions. PLD1 has been reported to have a peri-
nuclear localization in many different cell lines suggestive of distribution at the Golgi, 
endoplasmic reticulum or late endosome (Colley et al., 1997b; Kim et al., 1999; Sung et al., 
1999b). Consistent with this PLD1 was reported to be localized to endoplasmic reticulum, Golgi 
and to vesicles (Colley et al., 1997b). In addition, Freyberg and colleagues, have reported (using  
PLD1/2 selective antibodies) finding a differential distribution of the these enzyme on the Golgi 
apparatus in pituitary and kidney cells, where 25%-30% of both enzymes localized to Golgi with 
PLD1 distributing throughout the organelle and PLD2 concentrated at the rims of the Golgi 
cisternae (Freyberg et al., 2002; Freyberg et al., 2001). Nevertheless, other groups have not 
found Golgi localization (Hughes and Parker, 2001; Toda et al., 1999). Furthermore Brown and 





granules and lysosomes but not for markers of Golgi (Brown et al., 1998). PLD1 has also been 
reported to be at the plasma membrane in both un-stimulated cells (Kim et al., 1999) as well as in 
caveolae-enriched microdomains (Kim et al., 2002; Xu et al., 2000).  In recent work, PLD1 was 
shown to play a regulatory role in autophagy and was found to localize to the outer membrane 
autophagosome-like structures upon nutrient starvation (Dall'Armi et al., 2010). Finally, the 
concept of a dynamic translocating PLD1 has been reported by many, where PLD1 translocates 
towards the plasma membrane in response to stimuli (Du et al., 2003; Huang et al., 2005; Hughes 
et al., 2004).  
Unlike PLD1, PLD2 is generally most often reported to localize to the plasma membrane (Colley 
et al., 1997b; Du et al., 2004; Honda et al., 1999), but also to cytosol (Honda et al., 1999), in sub-
membranous vesicular compartments (Divecha et al., 2000) and to β-actin (Lee et al., 2001). It 
has also been reported that PLD2 was found to co-fractionate with caveolae (Czarny et al., 
1999), though this has been a matter of dispute (Kim et al., 2000). Similarly to PLD1, PLD2 has 
also been reported to dynamically translocate to plasma membrane ruffles in response to 
stimulation with serum (Colley et al., 1997b) or epidermal growth factor (Honda et al., 1999). 
As discussed above, the subject of the sub-cellular localization of PLD 1 and 2 are matter of 
debate and controversy. Discrepancies between published reports may reflect varying expression 
levels between cell types and systems employed. Furthermore there is considerable evidence that 
PLD binds to membrane vesicles that are constantly in flux in a cellular context. Thus, in such a 
setting the differential rates of vesicle trafficking across cell types may impinge on the steady 
state localization of the enzymes. Another confounding factor is that many of these localization 
studies rely on overexpression of tagged PLD isoforms. Although it is known that the PLD 





impact of the tags on the cellular distribution is not known (Frohman and Morris, 1999; Frohman 
et al., 1999). The discovery of new highly immunogenic isoform specific antibodies would be 
critical for future studies.  
2.4 PLD REGULATION  
2.4.1 Regulation overview 
 
The regulation of mammalian PLD is complex, and is mediated by a plethora of different factors. 
These regulators are thought to fall under two main categories: one is via signaling growth 
factors and mitogens-which implies phosphorylation by various signaling kinase including PKC 
family members, and the second, by small GTPases proteins of the Arf and Rho families. The 
specific regulatory program executed, or the PLD isoform activated, may however vary 
depending on the cell type or the nature of the extracellular stimulus.  
 
2.4.2 Regulation of PLD by Protein Kinase C  
 
Suspicions of protein kinase C involvement in PLD activation came about from a range of 
studies showing that protein kinase C (PKC) activators like calcium ionophores and phorbol 
esters such as phorbol 12-myristate-13-acetate (PMA)-a stable analogue of diacylglycerol, 
stimulated PLD activity (reviewed in (McDermott et al., 2004). The PKC family of enzymes are 
classified into three sub-families: the classical isoforms, the novel isoforms, and the atypical 
isoforms. The classical isoforms consist of PKC (α, β, and γ) and are stimulated by 
phosphatidylserine, diacylglycerol, and Ca2+ unlike the novel isoforms (δ, η, θ, and μ), and 
atypical isoforms (ζ and λ) (McDermott et al., 2004). Using both PKC selective (i.e  





inhibitors, as well as PKC depletion approaches using PKC siRNA, many studies have 
implicated partial or total inhibition of agonist-stimulated PLD activity (McDermott et al., 2004). 
It is noteworthy however, that where small molecule inhibitors are concerned, caution must be 
taken as to the involvement of PKC on PLD activation as one report demonstrates that the PKC 
inhibitor calphostin-c directly inhibits both PLD1 and PLD2 and may account for some PKC-
independent effects on PLD (Sciorra et al., 2001).  
Much of the effects on PLD exerted by the classical PKC’s are thought to involve 
phosphorylation. For example, PKC phosphorylates PLD1 on serine-2 threonine-147, and serine-
561 in response to PMA and mutation of these residues diminished PMA-stimulated PLD1 
activity (Exton, 1998; Kim et al., 2000). However, the classical PKCs may also exert their 
activation effects through kinase independent mechanisms (Chen and Exton, 2004; Hammond et 
al., 1997; Zhang et al., 1999).  As hinted above, PKC may exert its effect on PLD through (but 
not be limited to) direct interaction. If fact it has been demonstrated in one study that PKC 
directly interacts with the N-terminus of rPLD1 between residues 51 to 115, and a mutant 
lacking these residues was no longer able to mediate phorbol ester induced stimulation of PLD 
(Park et al., 1998). In this study, N-terminal deletions actually resulted in increased the basal 
activity of the resultant enzyme suggesting that these residues negatively regulate PLD activity. 
Thus it is thought that the PKC-PLD interaction may be to relieve this negative PLD auto-
regulation (Park et al., 1998).   
Since PLD enzymes are strongly dependent of PI(4,5)P2 for activity (Colley et al., 1997a; Colley 
et al., 1997b; Hammond et al., 1995; Hammond et al., 1997; Lopez et al., 1998),  one possibility 





PI(4,5)P2 is enriched, as both enzymes have been seen co-translocating to the plasma membrane 
upon agonist stimulation (McDermott et al., 2004). 
In addition to PLD1, PKC also interacts with PLD2 but the actual sites of interactions is not 
known (Han et al., 2002; Slaaby et al., 2000). Elsewhere it has been reported that insulin induces 
PLCγ mediated stimulation of PLD2 (Slaaby et al., 2000). Similarly to PLD1, PLD2 activation 
by insulin could be abrogated by specific PKC inhibitors such as bisindolylmaleimide and 
GÖ6976 demonstrating a functional link between these two enzymes during intracellular 
signaling (McDermott et al., 2004; Slaaby et al., 2000).  
Altogether the PKC regulation of PLD activation is intertwined and complex as PKC enzymes 
transduce a plethora of signals. The molecular mechanisms specifying which isoforms are 
stimulated, and which effectors impacted, is diverse and may involve direct as well as indirect 
mechanisms, which may in turn be contextual, an a reflection of nature of the stimulus as well as 
other contributing factors.  
2.4.3 Regulation of PLD by Arf 
 
As mentioned above (see chapter 1), Arf was originally purified and identified by two 
independent groups as the unknown cytosolic factor stimulated by GTPγS in the induction of 
PLD activity in HL60 ghost cell membranes (Anthes et al., 1991; Brown et al., 1993; Cockcroft 
et al., 1994; Geny and Cockcroft, 1992; Geny et al., 1993; Olson et al., 1991). 
All Arf proteins activate PLD, and brefeldin A, a fungal metabolite which inactivates some Arf 
isoforms (with the noted exception of Arf6) by way of inhibiting their exchange factor function 
has been used extensively to examine the effects of Arf on PLD activity in various systems 
(Morinaga et al., 1996).  The interaction site on PLD for Arf is not known, however, the cognate 





1995). In Arf1 this has been mapped to the α2 helix, part of the β strand and the N-terminal helix 
and its ensuing loop (Jones et al., 1999b). Several studies suggest that the n-terminus of PLD 
appears to be important for its regulation by Arf (Banno, 2002). The Arf mediated PLD 
stimulation may however likely require a role for accessory proteins such as Arf GEFs (guanine 
nucleotide exchange factors)  including  cytohesin1 (Meacci et al., 1997) GRP1 (Klarlund et al., 
1997), EFA6 (Franco et al., 1999), and the Arf Nucleotide Site Operner (ARNO)(Caumont et al., 
2000; Moss and Vaughan, 1998), as indicated by reconstitution studies (Brown et al., 1995; 
Caumont et al., 1998; Lambeth et al., 1995; Singer et al., 1995). Arf may also mediate the 
stimulation of PLD activity by an indirect mechanism, through stimulation of PIP5Kinase which 
generates PI(4,5)P2 a necessary co-factor for PLD activity (Brown et al., 1993; Hammond et al., 
1997). Arf1, Arf5 and Arf6 were all able to activate purified PI(4)P5K Iα in the presence of 
GTPγS and PA in vitro (Skippen et al., 2002). The PH domains of PLD isoforms 1 and 2, serve 
to bind PI(4,5)P2 and mediate the anchoring of the enzyme on membrane compartments in vivo 
(Yokozeki et al., 1996). 
2.4.4 Regulation of PLD by Rho family GTPases 
 
Rho family GTPases participate in a broad range of cellular events including, transcriptional 
activation, G1 cell cycle progression, cellular transformation and cytoskeletal arrangements, 
which include stress fiber formation (RhoA mediated), membrane ruffling (Rac mediated) , 
microspikes and filopodia (Cdc42 mediated) formation  (Nobes and Hall, 1995; Ridley and Hall, 
1992; Van Aelst and D'Souza-Schorey, 1997). Rho family of GTPases were first implicated in 
the regulation of PLD when GTPγS mediated PLD activation in neutrophils was found to require 
factors on the plasma membrane and cytosol which later were shown to be inhibited by the GDP 





direct activation of PLD1 by RhoA, Rac1 and Cdc42 was demonstrated using purified 
recombinant enzyme (Hammond et al., 1995; Hammond et al., 1997; Hodgkin et al., 1999; Min 
et al., 1998). Further studies demonstrate that Rho GTPases (including RhoA, Cdc42, Rac1, 
RalA) activate PLD in in a large range of cell types and tissues (McDermott et al., 2004). 
Yeast-2-Hybrid studies have revealed that that RhoA directly interacts with the C-
terminus of PLD1, specifically to basic residues located between amino acids 946-962 (Sung et 
al., 1997; Yamazaki et al., 1999). This has been shown to correspond to the switch 1 activation 
loop on RhoA (Bae et al., 1998). Mutational analysis of the PLD1 site relinquishes binding and 
thus defines possible in vivo roles for this interaction (Du et al., 2000; Yamazaki et al., 1999). 
Rac1 and CDC42 PLD associations have also been described elsewhere (Chae et al., 2008; 
Walker et al., 2000). 
The use of small molecule inhibitors, confirm the role of these small GTPases as activators of 
PLD. Toxins such as Clostridium botulinum C3-exoenzyme  and Clostridium difcile toxin-B 
which inactivate Rho proteins, have been shown have a negative impacts on PLD stimulation in 
response to a broad range of agonists (Hess et al., 1997; Malcolm et al., 1996; Ohguchi et al., 
1997; Schmidt et al., 1996a; Schmidt et al., 1996b; Sekine et al., 1989). 
Rho proteins may regulate PLD activity by an indirect mechanism involving the 
stimulation of PIP5Kinase and the generation of PI(4,5)P2 (Chong et al., 1994).  Consistent with 
this model, it has been reported that a pre-treatment of HEK cells with Clostridium difcile toxin-
B which inactivates Rho proteins, reduces PI(4,5)P2 levels and PLD activity, however, the 
addition of  PI(4,5)P2 to toxin-B-treated permeabilized HEK cells, fully restored basal and 





mechanism of PLD activation by Rho GTPase may also be by a myriad of indirect pathways and 
mechanisms in addition to the ones described here. 
 
2.4.5 Regulation of PLD by membrane binding  
 
As discussed above, PLD was demonstrated to be palmitoylated at a serine residue in its 
IGSANIN motif, the mutation of which abolishes activity and re-distributes the protein to the 
cytoplasm, for lack of ability to bind membranes (Manifava et al., 1999). As such palmitoylation 
is of major consequences to the regulation and the localization of the enzyme. 
Palmitoylation and membrane binding however is thought to be mediated by more than 
one part of the protein (i.e both N-and C-terminus) as proposed in one study where mutation in 
the cysteine-240 and 241 residues with the PH domain had similar effects of cytosolic re-
distribution, and reduction in protein activity of about 50-80%  in vivo (Sugars et al., 1999). This 
mutant however retained WT activity in vitro. Similarly, Xie and colleagues also observed 
reduced basal activity and weakened association to membrane when these residues were mutated 
in rat PLD1(Xie et al., 2000). These studies point to an overall theme where membrane binding 
and enzyme regulation and activity are linked. 
2.5 PLD IN CELLULAR PHYSIOLOGY  
2.5.1 A functional overview 
 
PLD’s have been implicated in almost every conceivable aspect of intracellular membrane 
transport and trafficking events including secretion, endocytosis, exocytosis, vesicular transport, 
maintenance of Golgi and ER structures, as well as in other cellular processes that include 





physiology and behavior (Cockcroft, 2001; Exton, 1999; Liscovitch et al., 1999; McDermott et 
al., 2004). Many of the theories concerning function of PLD and its cellular effectors, are based 
on events mediated by the PLD enzymatic product PA.  PA is a bioactive lipid implicated in 
several aspects of membrane trafficking, and can serve as an intermediate precursor for other 
signaling lipids such as diacylglycerol and lysoPA or it can also serve as a signal transducer in 
the activation of an number of key signaling kinases including phosphatidylinositol 4-phosphate 
5-kinases (type I) and mTOR (mammalian target of rapamycin) kinase (Cazzolli et al., 2006). It 
has a cone-shaped topology (see Fig. 21) which confers  the capacity to physically deform 
membranes to promote negative curvature of membrane lipid bilayers in facilitating fusion and 
fission events (Blackwood et al., 1997; Kooijman et al., 2003; Kozlovsky et al., 2002).     
2.5.2 PLD in vesicular transport 
 
Insights into the molecular function of PLDs in cells were garnered when it was discovered that 
PLD enzymes were sensitive to stimulation by members for the Arf family with (as described 
above) established roles in vesicle trafficking at the endoplasmic reticulum, Golgi apparatus and 
plasma membrane. Thus it was supposed that PLD proteins were possibly involved in similar 
roles (Massenburg et al., 1994). Specifically, initial studies by Cockcroft and colleagues, showed 
that agonist stimulation of neutrophils was found to increase the levels of PA followed by an 
accompanied accumulation of diacylglycerol (Cockcroft, 1984; Geny and Cockcroft, 1992).  
Subsequent studies demonstrated a requirement for GTPyS a non-discriminatory activator of all 
G-proteins, in the activation of PLD activity in permeabilized HL60 cells and this requirement 
was later linked to Arf (Brown et al., 1993; Cockcroft et al., 1994; Geny and Cockcroft, 1992). 
Further studies showed that PLD (especially PLD1) was highly responsive to  and could be 





al., 1995; Liang et al., 1997; Massenburg et al., 1994; Tsai et al., 1998). In addition Sung and 
colleagues, found that removal of the 380-N-terminal-most amino acids for PLD2 renders the 
protein Arf insensitive, suggesting that PLD2 may be activated by Arf under certain regulatory 
settings (for example by stimulation)(Sung et al., 1999a).  As mentioned above due to the well-
defined role for Arf in transport including functions in budding of coated vesicles, the discovery 
that Arf proteins are PLD regulators, implicated PLD in similar processes (Orcl et al., 1993; 
Rothman and Orci, 1992).  
 
2.5.3 PLD in vesicle formation (endocytosis at the plasma membrane and budding at the 
Golgi)  
 
There is general agreement that though PLD1 and 2 are mostly membrane localized their 
distribution is highly heterogeneous with notable enrichments at (but not limited to) Golgi 
(Freyberg et al., 2002; Freyberg et al., 2001) and plasma membrane (for PLD2) (Colley et al., 
1997b; Du et al., 2004; Honda et al., 1999). Vesicle budding from the Golgi-during secretion, 
exocytosis, and from the plasma membrane during endocytosis, both involve the formation of 
coat proteins which are recruited to and participate in the process of cargo selection and 
membrane deformation (Barr and Huttner, 1996; Chen and Shields, 1996; Nickel et al., 1994). 
Clathrin-coated vesicles that bud from the plasma membrane, are involved in the trafficking of 
various receptors such as the metabotropic glutamate receptor (Bhattacharya et al., 2004), 
angiotensin II receptor (Bhattacharya et al., 2004), mu-opioid receptor (Koch et al., 2003) and 
the epidermal growth factor  receptor (Shen et al., 2001), all of which are regulated by PLD. 
These vesicles, along vesicle populations that bud from the trans-Golgi network both participate 





coats whilst those from the trans-Golgi network contain AP1, and these are involved in ferrying 
cargo to endosomes and to different sub-cellular parts respectively. There is substantial evidence 
that AP1 recruitment to membrane is mediated by Arf1 whilst AP2 recruitment to the plasma 
membrane is not (Jones et al., 1999a). This information on the regulation of adaptor recruitment 
has been driven mainly from in-vitro studies using brefeldin A, a fungal metabolite which 
negatively targets GTP-exchange factors responsible for activating Arf (Robinson and Kreis, 
1992).  
A role for Arf-regulated PLD activity in the budding of COP1-coated vesicles from the Golgi 
was suggested when PLD activity was abrogated in CHO cells treated with brefeldin A (Ktistakis 
et al., 1995; Ktistakis et al., 1996). Further experiments suggested that the role of Arf at the 
Golgi was partly to regulate PLD derived PA production (Jones et al., 1999a; Roth et al., 1999; 
Roth and Sternweis, 1997) which facilitated budding. This described role for PLD has been a 
subjected of controversy as described below.  
2.5.4 Evidence supporting a role for PLD in vesicle formation  
 
The first line of evidence that supports a role for PLD at the Golgi is that the enzymes are 
localized there, and this is depicted in a wide range of studies including one detailed study where 
PLD1 and 2 selective antibodies,  used to determine the localization of the enzymes in cultured 
pituitary and kidney cells, reported that 25-30% of both enzymes localize to the Golgi apparatus, 
with PLD1 being distributed throughout the organelle and PLD2 to the rims of the Golgi 
cisternae (Freyberg et al., 2002; Freyberg et al., 2001).  
Further studies utilizing primary alcohols in intact as well as broken cells and purified Golgi 
membranes showed that PLD activity is required for the structural integrity of the Golgi, 





idea are other reports showing that PLD-mediated hydrolysis of phosphatidylcholine is required 
for formation of Golgi vesicles and for the stimulated release of secretory vesicles from the 
trans-Golgi network (Chen et al., 1997; Ktistakis et al., 1996). One interpretation of these 
findings is that PLD1 which is activatable could provide stimulus coupled release of Golgi 
vesicles whilst, PLD2 which is constitutively active performs the “housekeeping” roles at the 
Golgi.  
Taken together it is proposed that phospholipids are a common denominator underlying budding 
mediated by Arf (Tuscher et al., 1997), where phosphatidylcholine hydrolysis by PLD generates 
PA, which potentially regulates PI(4,5)P2 synthesis at PLD active compartments, by involving 
the stimulation of a possible Golgi resident PIPKinase (Jenkins et al., 1994).  
2.5.5 Evidence against a PLD role in vesicle formation 
 
An opposing school of thought holds that the evidence linking PLD to vesicle formation 
(especially at the Golgi) is largely circumstantial (reviewed in (Jones et al., 1999a). One piece of 
information cited holds that AP-1 recruitment to the trans-Golgi network is not stimulated by 
bacterial PLD-which does not require PI(4,5)P2 as a co-factor, nor was it affected by neomycin 
(which binds and inhibits PI(4,5)P2). Arf however was essential for this activity. This indicates 
that Arf can function towards coat recruitment without involving PLD; and in addition, AP-1 
recruitment to membranes does not require PI(4,5)P2 (Simpson et al., 1996; West et al., 1997). 
A second piece of evidence suggests that although BFA (which negatively regulates 
certain Arf isoforms) has been shown to inhibit PLD activity in some cases this however is not a 
universal paradigm, as it was reported that BFA does not affect PLD activity in stimulated HL60 
cells or membrane preparations in vitro (Guillemain and Exton, 1997; Ktistakis et al., 1995; 





Third, although it is known that the yeast PLD homologue Spo14 is required for sporulation-a 
membrane trafficking-intensive event (described above), homozygous mutants of this alleles, are 
viable, and the gene in not required for vegetative growth (Ella et al., 1996; Waksman et al., 
1996). These observations suggest that it is possible that similar mechanisms could occur in 
mammalians cells where budding does not require PLD.  
Future efforts towards resolving these conflicts would have to rely on the availability of 
high immunogenic antibodies that are able to differentiate between the different endogenous 
PLD isoforms as well as the development of null systems in mice.  
2.5.6 PLD in exocytosis  
 
Though it is unclear whether PLD plays a role in vesicle budding, vesicles do eventually bud, 
and afterwards, must be delivered to their respective destinations. During exocytosis, vesicles 
and granules are delivered to the plasma membrane where they deliver and/or release their 
content. This may be towards various ends including membrane expansion, secretion, or 
phagocytosis to name a few. Early work implicating PLD in exocytosis and regulated secretion 
came from using primary alcohols, such as ethanol, and studies showed that exocytosis in mast 
cells are neutrophils was dependent on PLD activity (Gruchalla et al., 1990; Lin et al., 1991; 
Stutchfield and Cockcroft, 1993; Xie et al., 1991; Yuli et al., 1982).  Other similar work done in 
neutrophils, PtdCho-12 cells and RbL-2H3 cells suggested that these mechanisms were 
conserved (McDermott et al., 2004).    
2.5.7 Arf is involved in PLD mediated exocytosis 
 
Reconstitution studies prompted proposals and later demonstrated that Arf proteins were 





pathways were by-passed by permeabilizing cells (thus inducing cytoplasm leakage) in the 
creation of minimal systems for studying the necessary components for stimulated secretion. 
Lesions (of approximately 15nm) in the plasma membrane (induced by streptolysin O, a pore-
forming bacterial cytolysin), permits leakage of cytoplasm, and concomitant loss of freely 
diffusible cytosolic proteins including phospholipase C (150 kDa), Arf (20 kDa)-the cytosolic 
diffusible pool, and phosphoinositide 3-kinase whilst retaining membrane bound and/or non-
diffusible proteins (such as Rho and Rac) which remain cell-associated (Cunningham et al., 
1996; Fensome et al., 1996; Kular et al., 1997; Leino et al., 1999; Stutchfield and Cockcroft, 
1988). In one report, HL60 cells which become refractory to stimulation with GTPγs with regard 
to secretion and PLD activity, was founded to be reconstituted with exogenously added Arf1 
(Fensome et al., 1996). PI(4,5)P2 activity was also stimulated in this setting. This provided direct 
evidence that Arf and PI(4,5)P2 were required for exocytosis.  
These findings favor a hypothesis where Arf, by regulating PLD derived PA, functions in 
exocytosis by promoting PI(4,5)P2 synthesis, which is established to be central to exo-endocytic 
events at the plasma membrane. In support of this, phosphatidylinositol transfer protein (PITP), a 
cytosolic protein which enhances PI(4,5)P2 synthesis was also identified to be able to used 
interchangeably with Arf6 as a regulator of exocytosis (Fensome et al., 1996). Finally, one study 
showed that an n-terminal peptide which disrupts Arf6-membrane interactions inhibited both 
PLD activation and catecholamine secretion in chromaffin cells (Vitale et al., 2002a). 
2.5.8 PLD in vesicle fusion at the plasma membrane 
 
The phosphoinositide PI(4,5)P2 is concentrated at the plasma membrane and has multifaceted 
roles in regulating membrane dynamics and signaling at the plasma membrane (Di Paolo and De 





trisphosphate and diacylglycerol which have direct functions in exo-endocytosis, it also regulates 
through direct interactions with cytosolic and membrane proteins (Berridge and Irvine, 1989; Di 
Paolo et al., 2004). Localized production of this lipid may regulate fusion events through 
interaction with components of the Ca2+-dependent machinery for exocytosis, such as 
synaptotagmin (Kim et al., 2012) or by interacting with other PH domain or phospho-tyrosine 
binding proteins (Martin, 1998).  PI(4,5)P2 may also locally mediate local re-organization of the 
actin cytoskeleton to facilitate fusion events (Dumitrescu Pene et al., 2005). Altogether, this data 
suggests that PLD may play an indirect role in actin cytoskeleton reorganization through the Arf-
dependent activation of PIP5Kinase, and the synthesis of PI(4,5)P2. A direct role for PLD in 
fusion however, can be mediated by its metabolic product PA, which as discussed has innate 
fusogenic properties that can form energetically stable complexes with SNARE proteins to 
facilitate fusion events (Cazzolli et al., 2006; Roth, 2008) . Finally convincing work form 
Zeniou-Meyer et al (Zeniou-Meyer et al., 2007) using a PA probe expressing the PA-binding 
domain of the yeast snare protein Spo20p, demonstrated that PLD1 is activated in secretagogue-
stimulated cells to produce PA at the plasma membrane at secretory granule docking sites (Fig. 
23), demonstrating a role for PA in vesicle fusion. 
 
2.5.9 PLD2 in receptor endocytosis 
 
Overall, the regulation of receptor-mediated endocytosis appears to be a function for PLD2 in 
cells (Jenkins and Frohman, 2005). For example, PLD2 mediates EGF receptor signaling and has 
also been shown to be required for efficient endocytic recycling of the transferrin receptor 
(Padron et al., 2006; Slaaby et al., 1998). Furthermore, PLD2 has been shown to be functionally 





receptor and the angiotensin II receptor (Bhattacharya et al., 2004; Du et al., 2004). Still, μ 
opioid receptor endocytosis has been shown to be dependent of PLD2 function, defining a role 
for PLD2 in the internalization of this receptor. Finally, endocytic trafficking of the cannabinoid 
receptor isoform 1 has been also shown to be mediated by a PLD2-dependent pathway (Koch et 
al., 2006).  
2.6 RESULTS AND DISCUSSIONS 
2.6.1 PLD conditional KO mice: Tool generation and validation  
 
As mentioned above efforts to better define the isoform specific contributions PLD enzymes in 
cells have been hampered by lack of immunogenic antibodies and the lack of functional null 
systems of both enzymes. Thus in taking strides towards a genetic approach to understanding 
how PLD and PA regulates membrane and receptor trafficking, our lab has accomplished the 
genetic engineering of mice designed for the conditional ablation of the PLD2 gene using the 
Cre-loxP system (Fig. 24).The PLD2 gene was disrupted by targeting exons 13,14 and 15 within 
the N-terminal-most catalytic HKD motif for deletion using the Cre-loxP system (see description 
in chapter 1). Southern blot analysis of genomic DNA showed loss of PLD2 PCR product from 
tails derived from PLD2 knockout mice (Fig. 24b). 
As already discussed, in the presence of primary alcohols such as ethanol or 1-butanol, PLD, in a 
transphosphatidylation synthesizes PEtOH or PtdBut respectively, at the expense of PA. Because 
intracellular PEtOH/PtdBut is relatively stable, its levels can be readily detected and provides an 
experimental readout or PLD activity. Here, MEFs were metabolically labeled with 
[3H]myristate in the presence of butanol followed by extraction and characterization of lipids for 
the accumulation of [3H]-PtdBut. Fibroblasts derived from two independent PLD2 WT and KO 





PLD2 KO mice are viable and exhibit no obvious defects at the organismal level, however in a 
recent study, PLD2 ablation was shown to rescue memory deficits and confer synaptic protection 
in Swedish APP mice (a mutant mice model bearing an Alzheimer disease-causing mutation in 
the APP gene) (Oliveira et al., 2010).  
2.6.2 Examining the expression levels of various proteins in response to PLD2 ablation  
 
Immortalized cell cultures derived from PLD2 KO mice were subjected to similar assays as 
described for Arf6 (see chapter 1). WT and KO MEFs were assayed for compensatory changes 
(as a result of PLD2 ablation) in the expression levels of selected proteins. These candidates 
included: clathrin, rab5, vps35 (see the retromer description in chapter 1), gm130, rab7, FAK, 
annexin (a scaffolding protein involved in exocytosis (Gerke and Moss, 1997), rab11, and 
flotillin (a lipid raft enriched protein involved in vesicular trafficking (Glebov et al., 2006). Of 
these rab5, rab7, gm130 and flotillin showed a 32% , 82% , 3-fold, and 55% increase in protein 
expression respectively, whilst annexin alone showed a 54% decrease in protein expression 
levels (Fig. 25). These alterations in the expression profiles of these proteins may reflect the 
pleiotropic role for PLD2 and possibly its catalytic product PA, in trafficking pathways and cell 
physiology. Of note, the drastic increase in the expression levels of gm130 (cis-Golgi marker) in 
the KO MEFs is consistent with the finding that PLD2 is localized to the rims of the cis-Golgi 
and is thought to play a role in vesicular transport at this compartment (Freyberg et al., 2002).  
Future experiments aimed at dissecting the physiological significance of these changes, will first 
involve rescue experiments by exogenous re-expression of PLD (WT and mutant) alleles in these 
MEFs to ensure that these changes are PLD2 specific.  






We then subjected cells to similar transferrin trafficking assays described above for Arf6. Results 
show that transferrin uptake was severely attenuated in the PLD KO MEFs (Fig. 26a) and this 
was not due to the differential expression of the transferrin receptor levels (Fig. 26b).  
To examine the internal distribution of  transferrin in cells, cells were pulsed for 30min with 
Alexa-coupled transferrin after which they were fixed and stained with Rab11 (a marker of the 
recycling endosomes). Similarly to published reports (Padron et al., 2006) transferrin appeared to 
accumulate in a peri-nuclear compartment which was positively labeled for Rab11 (Fig. 27a). 
This Rab11 compartment appeared to be larger in the KO MEFs although this was not due to 
increased Rab11 protein expression (Fig. 25).  This increased staining in the KO MEFs may be 
due to an aggregation of Rab11 positive vesicles. 
2.6.4 Transferrin Recycling  
 
The above results indicated that endocytosis was severely inhibited in the KO MEFs. We 
reasoned that an internal accumulation of transferrin may arise therefore from decreased 
recycling of the receptor in the KO MEFs, which over iterative rounds of receptor trafficking 
may deplete the steady-state surface levels of the receptor, leading to a subsequent delay in 
endocytosis. Thus we tested whether recycling was delayed in these MEFs. Cells were subjected 
to a transferrin recycling assay (similar to the one described for Arf6 in chapter 1). As expected 
results show that transferrin recycling was kinetically delayed in these cells (Fig. 28).  Altogether 
these results support a model where PLD functions in the recycling of transferrin receptor to the 
plasma membrane, and in the absence of PLD 2 transferrin and its receptor accumulates in the 
recycling endosomes. This may in turn deplete steady state surface pools of transferrin receptor, 





2.6.5 EGF trafficking  
 
Similarly to Arf6 MEFs, we also examined epidermal growth factor degradation kinetics in the 
PLD MEFs. PLD has been implicated to participate in epidermal growth factor induced signaling 
in a variety of cell types (reviewed in (Lee et al., 2009). Perhaps unsurprisingly therefore, steady 
state levels of epidermal growth factor receptor were drastically reduced in the KO MEFs (Fig. 
29) although the kinetics of degradation within genotypes appeared similar. The nature and 
physiological significance of this result is however unclear.  
Future investigations will similarly entail rescue experiments by exogenous re-expression 
of PLD2 alleles (or its mutants) in these MEFs to determine the specificity of this phenotype. 
2.7 CONCLUDING REMARKS AND FUTURE STUDIES  
 
PLD is a major source of PA pools that are relevant in multifaceted signaling and trafficking 
roles underlying cell physiology.  We have determined in our studies that PLD2 ablation leads to 
a variety of alterations in the expression profile of several trafficking related proteins as well as 
defects in the trafficking of epidermal growth factor and transferrin receptors, reflecting a multi-
faceted role for this enzyme in physiology in this system. Future investigations will entail rescue 
experiments, to establish the specificity of these phenotypes by exogenous re-expressing PLD 
along with its mutant alleles in these MEFs (all of which are available in the lab).  
Though much has been described concerning the roles of PLD and PA, progress in this research 
area has been hampered by the lack of availability of high affinity reagents to endogenous PLD 
and PA, and this has resulted in many conflicting reports as to the localization of PLD and to the 
reproducibility of ascribing functions to PLD or its isoforms at the sub-cellular level. Towards 





there is concern regarding the specificity of this approach and to off target and toxicity effects of 
this approach, even when used in the context of suitable controls. In this regard the widespread 
use and availability of specific inhibitors would be useful in sheading light to this area of 
research. A recent study has reported on a PLD inhibitor FIPI (5-fluoro-2-indolyl des-
chlorohalopemide) which was found to not to perfectly model the inhibitory effects of alcohol in 
some settings, a finding which underscores the necessity to discover new and more refined 
approaches to investigating the cellular relevance of PLD and PA (Su et al., 2009b). PLD KO 
models, like the one described here, though generally lacking in the field, will serve to provide 
important functional insights into future work. Finally, mass spectrometry combined with 
lipidomics is emerging to be one of the most powerful tools available, to study contextual acute 
transient lipid changes which is indispensable for a thorough understanding of how lipid 
enzymes like PLD is regulated in different cellular and disease contexts. Recently this 
technology has been exploited to characterize phosphoinositide profiles form disease samples 
providing insights into how phosphoiositides and their related enzymes are misregulated in these 












































Figure 1. Two hypothetical models for Rac recruitment by integrin 
1.) Talin is recruited by binding to the cytoplasmic tail of β integrin and in turn associates with 
the p125Fak (FAK). FAK associates with p130Cas which recruits DOCK180/ELMO (a Rac 
GEF), which then activates Rac. 2.) Alternatively, integrin binds α-actinin which binds to 
zyxin. Zyxin in turn recruits the Vav (a Rac GEF) which leads to the activation of Rac at 











































Figure 2. Ral1 GTPase regulates fusion, by coordinating exocyst subcomplex assembly.  
Ral 1 mediates exocyst-coordinated vesicle fusion by a dual subunit interaction with Sec5 and 




























Figure 3. Two cooperating mechanisms lead to Rho stimulated stress fiber formation. 
In the first mechanism, activated Rho binds its effector p140mDia which recruits the actin-
restructuring protein profilin to sites of FA formation for stress fiber formation. In the second 
mechanism, Myosin is induced to bind actin when it is phosphorylated on its regulatory light 
chain by myosin light-chain kinase (MYL kinase). This kinase is a target for the Rho effector 
ROCK (Rho-associated protein kinase). Rock also promotes MYLK phosphorylation by 














Figure 4. Features of the Arf family of small G-proteins.  
A) A schematic representation of the basic primary structure of Arf proteins. All Arf proteins 
are myristoylated on the second N-terminal glycine residue, a post-translational modification 
that facilitates membrane binding. The two switch regions regulate effector binding and are 
interlinked by an inter-switch region which coordinates nucleotide and membrane binding. B) 
The molecular structure of GTP and GDP bound Arf1. Binding of GTP displaces the N-
terminal helix from its pocket and into a confirmation that is conducive to membrane binding 
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Figure 5. A strategy for the acute deletion of Arf6. 
A) Due to the relatively short coding sequence (~4004bp), the entire Arf6 gene was floxed with 
loxP sites. A FRT-NEO-FRT-loxP cassette was inserted downstream of the Arf6 coding 
sequence and a second flanking loxP sequence was inserted at an upstream AvrII site. The 
genomic sequence was targeted with a positive selection lox integration vector to generate a 
targeted allele. Resultant Arf6Flox Neo/+mice were bread with mice bearing the inducible 
CreER transgene (CreER) to generate Arf6FloxNeoCreER/+ mice which were then 
intercrossed to generate mice bearing homozygous alleles. Embryos generated from these mice 
were then homogenized to form primary fibroblasts, which were then immortalized used the 
3T3 protocol to from cell lines. B) Fibroblasts from (A) were either induced for gene deletion 
with tamoxifen or inoculated with vehicle. Resultant MEFs were harvested from culture and 
genomic DNA was amplified by PCR showing WT (+/+) and knockout (-/-) genotypes. C). 
MEFs were harvested and extracts were prepared and probed by Western blot. The result 





















































** *** *** ***
ARF6 deletion
Figure 6. Tamoxifen induces loss of Arf6 immunoreactivity in cultured fibroblasts. 
Cells were plated at low density (350cells/mm2) in the presence of 10uM tamoxifen or vehicle 
(DMSO) for three days, after which they were passaged for three more days in the absence of 
drug. Results show a gradual loss of Arf6 immunoreactivity in cells treated with tamoxifen. 
Statistical analysis was carried out using the Student’s t-test. **P < 0.01; ***P < 0.001. Error 


















































Figure 7. The expression profile of candidate proteins in Arf6 WT and KO MEFs. 
Extracts were harvested and prepared from Arf6 WT and KO MEFs and candidate protein 
expression profiles were analyzed by Western blot. Results show a 20% increase in the 
expression levels of clathrin with negligible changes the expression of other proteins tested. 
Statistical analysis was carried out using the Student’s t-test. *P < 0.05. Error bars represent 





























Figure 8. The transferrin cycling overview. 
At the slightly alkaline extracellular pH of 7.4, transferrin (ovals) binds iron (step1) and is 
endocytosed by clathrin mediated endocytosis (step 2) into the acidified endosomes where 
transferrin undergoes a conformational change releasing bound iron (step3). Transferrin 
however remains bound to its receptor and is recycled back to the plasma membrane where it 



















































































Figure 9. The kinetics of transferrin uptake in Arf6 WT and KO MEFs. 
A) Arf6 WT and KO MEFs were starved for 1hr and then pulsed with biotin labeled transferrin 
(20uug/ml) for the indicated time points after which they chilled on ice. Surface probe was 
stripped with a mild acid wash, and cells were rinsed with PBS and harvested. Extracts were 
then prepared from these cells and internal levels of transferrin was probed by Western. B) 
Extract samples from A. were also probed for total levels of transferrin receptor. Error bars 
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Figure 10. Transferrin recycling kinetics is delayed in in Arf6 KO MEFs. 
WT and KO MEFs were starved for 1hr and pulsed with biotin-labeled transferrin for another 
hour. Afterwards, cells were chilled on ice to block further uptake of the probe. Surface bound 
probe was detached with a mild acid wash. Following subsequent washing with PBS, cells 
were then pulsed with excess un-labeled Holo-Transferrin (600ug/ml) for indicated times, after 
which they were washed, harvested, and lysed. Lysates were then analyzed by Western blot for 
internal levels of labeled transferrin. Results show that transferrin recycling is delayed in Arf6 
KO MEFs, and this is characterized by a larger residual pool of transferrin in the KO MEFs per 
unit time. Statistical analysis was carried out using the Student’s t-test. *P < 0.05; Error bars 



































Figure 11. Model of the endocytic itinerary for the EGF receptor. 
Ligand binding stimulates the phosphorylation of the EGF receptor which induces its 
translocation from caveolae into clathrin-coated vesicles, a process that relies on several 
adaptor proteins and enzymes including dynamin and Eps15. Following endocytosis, vesicles 
are uncoated and the receptor is sorted into early endosomes. Cbl, (a ubiquitin ligase and early 
responder to receptor phosphorylation) promotes the ubiquitination of the receptor, a 
modification which facilitates the ESCRT mediated sorting of the receptor into MVBs, a major 
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Figure 12. Epidermal growth factor degradation in Arf6 WT/KO MEFs. 
Cells were starved in serum-free media for 24 hours after which they were innoculated with 
serum-free media containing 100ng/ml EGF for two hours. The media was subsequently 
swapped and incubated in serum-free media for the indicated time points after which cells were 
harvested. Lysates were prepared and examined by Western blot. Statistical analysis was 




























Figure 13. Cell spreading is kinetically delayed in Arf6 KO MEFs. 
A)  In order to quantify cell size during spreading cells were spread, fixed on coverslips, and 
subsequently immersed in a staining solution containing PBS and alexa-coupled wheat germ 
agglutinin to stain the cell surface. Coverslips were the imaged directly (not mounted) in a live 
imaging chamber and DIC and fluorescent images were acquired at low magnification using a 
(10x) objective lens. Finally images (middle panel) were thresholded in image-j into demarcate 
the cell outline (right –panel) and cell size was measured using the wand measuring tool. B) 
WT and KO stable adherent cells were stained as in (A) and cell size was quantified. Results 
show that there is no obvious difference in cell size of stable adherent cells due to Arf6 deletion. 
C) Cells were detached and re-suspended for 30min at 37
0
C in recoding media (Ringers Buffer) 
after which they were plated onto coveslips coated with 5µg/ml fibronectin, followed by 1% 
BSA, to block non-specific adhesion sites. Cells were then spread for the indicated time points 
after which they were fixed with 4% PFA, then stained and quantified as described in A. C) 
Cells were treated as in B, but plated rather on 10µg/ml of fibronectin. Results show that cell 
spreading is delayed in Arf6 KO MEFs under these conditions. In all experiments, results are 
the total of three independent experiments (~1300cells/ condition (i.e WTx5min=1condition). 
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Figure 14. Arf6 facilitates CtxB delivery to the cell surface during cell spreading. 
A.) Image shows CtxB (raft)-labeled vesicles co-localized with microtubules.  Cells were 
pulsed for 20min with Alexa555-CTxB, trypsinized and re-suspended for 30min at 37
0
C. 
Subsequently cells were plated on fibronectin coated coverslips (10µg/ml) (blocked with 1% 
BSA) and spread for 20min, at which point they were fixed and stained with tubulin antibody. 
B) Arf6 KO cells have reduced surface levels of CtxB (rafts) at 20min of cell spreading. Cells 
were detached and suspended at 37
0
C for 30min after which they were either chilled and 
incubated with CtxB-biotin in suspension (T=0) for 15min, or plated on fibronectin (10µg/ml) 
and allowed to spread for 20min. They were then chilled, incubated with CtxB-biotin for 
15min. Cells were then washed to remove unbound probe and lysed. Extracts were then 
prepared for Western and probed with streptavidin antibody. Results show reduced surface 
CtxB label in KO MEFs implicating Arf6 in raft trafficking to the plasma membrane during 
cell spreading. Statistical analysis was carried out using the Student’s t-test. **P < 0.01. Error 




































Figure 15. Arf6 and CtxB co-localize with the VPS35 component of the retromer complex. 
Cells were pulsed for 20min with Alexa555-CtxB, trypsinized and re-suspended for 30min at 
37
0
C. Subsequently cells were plated on fibronectin coated coverslips (10µg/ml) (blocked with 
1% BSA) and spread for 20min, at which point they were fixed and stained for VPS35. B) Cells 
transfected for 24hrs with Arf6-eGFP, were re-suspended and spread as in (A). They were then 







































Figure 16. The retromer complex  
A.) The retromer complex. The retromer complex, transports acid hydrolases receptors between 
endosomes and trans-Golgi network (see below). SNX1/2 are sorting proteins with PX-Bar 
domains that that couple membrane binding (i,e, to PI(3)P ;see red arrow) to vesicle tabulation 
during membrane fission. VPS35, VPS29 and VPS26 comprise the core domain of the retromer 
complex, which is thought to perform cargo recognition and regulatory roles. In a working 
model, SNX1/2 proteins are recruited to membrane via their PX and BAR domains, and the 
core domain is then recruited through lateral interactions with the SNX proteins. Note the 
depiction here represents a cross section of a tubule encapsulated by retromer. Reproduced 
from (Bonifacino and Rojas, 2006). B) Retromer complex mediated trafficking. Retromer has 
been implicated in the endosomal-to-Golgi transport of receptors such as the cation-
independent mannose-6-phosphate, and the Wnt receptor Wntless (Bonifacino and Hurley, 
2008)(see #2). In our experimental paradigm, cells (transfected and/or not) are pulsed with 
Alexa-labelled CtxB (#1) for 20min, after which they are detached. Upon cell detachment, loss 
of integrin-mediated anchorage triggers the endocytosis of raft (CtxB labeled) membrane  to the 
recycling endosomes. Re-adhesion triggers their return to the plasma membrane in an Arf6 
dependent manner (Balasubramanian et al., 2007)(#3).  An Arf6 regulated role for retromer in 































Figure 17. VPS29 and CtxB co-translocate to the plasma membrane during spreading. 
Cells were transfected with VPS29-yfp cDNA for 24hrs and subsequently pulsed for 20min 
with Alexa555-CtxB. Cells were then trypsinized and re-suspended for 30min at 37
0
C. 
Subsequently cells were plated on fibronectin coated coverslips and spread for 20min, whilst 
being imaged in live. Results show that CtxB and VPS29 component of the retromer core, 
translocate towards the plasma membrane during cell spreading. This suggests a relationship 
between Arf6 (which regulates CtxB delivery to the plasma membrane) and retromer in raft 







Figure 18. PI(3)P is relevant for cell spreading. 
A) Cell spreading is accompanied by a specific increase in the phosphoinositide PI(3)P as 
determined by HPLC. B) This increase in PI(3)P is concomitant with a high degree of co-
localization between CtxB (Arf6 regulated raft marker), as determined by the PI(3)P probe, 
Fyve-eGFP.  Statistical analysis was carried out using the Student’s t-test. Error bars represent 
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Phosphatidic Acid (PA) Phosphatidylalcohol
Hydrolysis:  using water Transphosphatidylation: using alcohol
Figure 19. The PLD catalysis reaction. 
PLD converts phosphatidylcholine to phosphatidic acid using water as a nucleophile. However 
in the presence of primary alcohols (like ethanol) the enzyme favors a transphosphatidylation 
reaction that produces the corresponding phosphatidylalcohol at the expense of phosphatidic 
acid. Transphosphatidylation is a hallmark reaction of PLD enzymes and has been used to study 






















Figure 20. PLD hydrolysis and transphosphatidylation reaction. 
Catalysis begins with the binding of substrate (step1), forming a covalent enzyme-substrate 
(PLD-PA) intermediate (step2). Subsequently, hydrolysis or transphosphatidylation proceeds 
with a nucleophillic attack on the phosphodiester group of this intermediate using water or 
alcohol respectively, yielding phosphatidic acid or the corresponding phosphatidylalcohol 































Figure 21. Phosphatidic acid and lipid curvature 
Phosphatidic acid is a cone shaped lipid consisting of two acyl chains and no head group. 
Accordingly when enriched in the inner leaflet of the plasma membrane, it induces negative 
curvature and the inward bending of the membrane, a process that facilitates fusion and fission 
















Figure 22. Mammalian PLD structure. 
Boxes represent regions of highly conserved sequences. Interaction sites for several effectors 
are depicted. The loop region is not present in PLD2 but unique to PLD1. See text for further 
























Figure 23. Phosphatidic acid is up-regulated on peripheral space between secretory 
granules and the plasma membrane during stimulated exocytosis in PC12 cells. 
The peripheral cytoplasm shows intense increase in phosphatidic acid (labeled by phosphatidic 
acid-specific probe, EGFP-phosphatidic acid) in stimulated chromaffin cells (D), relative to 
resting controls, (C). Phosphatidic acid strongly labels the regions adjacent to the granules and 
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Figure 24. PLD2 knockout mice generation and characterization. 
A) Exons 13,14 and 15 of the PLD2 gene were floxed (using targeting vector) with LoxP sites 
containing in internal FRT-flanked selection marker (neo cassette), downstream of exon 15. 
The neo cassette was excised using Flp/FRT mediated deletion giving rise to the floxed allele.  
Final disruption of the PLD1 gene was mediated with Cre recombinase. B) Southern blot 
analysis of genomic DNA that was extracted from the tail of mice derived from Pld2+/– mouse 
intercrosses. The sizes of the wild-type and mutant alleles are indicated (4.2 kb and 11.2 kb, 
respectively) (Oliveira et al., 2010).C) Total phospholipase D (PLD) activity in mouse 
embryonic fibroblasts derived from two independent PLD2 WT and KO mice. PLD activity 
was measured by accumulation of [3H]-PtdBut in MEFs (passage 3) metabolically labeled with 
[3H]-myristate at 50µCi/ml. To allow for the production of [3H]-PtdBut, serum-starved cells 
were incubated with 0.3% Butanol-1 for 30 min. Clones WT1/KO1, n=6, p<0.01; clones 






















































Figure 25. The expression profile of candidate proteins of PLD2 WT and KO MEFs. 
PLD WT and KO MEFs were harvested and lysed; extracts were prepared and analyzed by 
Western blot to examine candidate protein expression. Statistical analysis was carried out 



















































































Figure 26. The kinetics of transferrin uptake in PLD2 WT and KO MEFs. 
A) PLD WT and KO MEFs were starved for 1hr and then pulsed with biotin-labeled transferrin 
(20µg/ml) for the indicated time points after which they chilled on ice. Surface probe was 
stripped with a mild acid wash, cells were rinsed (1xPBS) and harvested. Extracts were then 
harvested and internal levels of transferrin was probed for by Western blot. B) Extract samples 





























































Figure 27. Transferrin accumulates in a Rab11 compartment in the PLD2 KO MEFs. 
PLD WT and KO MEFs were pulsed with Alexa-labeled transferrin for 30min. Afterwards, 
cells were fixed and stained with the recycling endosomal marker (Rab11). B) Quantification of 



















































Figure 28. Transferrin recycling kinetics is delayed in in PLD KO MEFs. 
WT and KO MEFs were starved for 1hr and pulsed with biotin-labeled transferrin for another 
hour. Afterwards, cells were chilled on ice to block further uptake of probe, and surface bound 
probe was detached with a mild acid wash. Following subsequent washing with PBS, cells were 
then pulsed with excess un-labeled holo-transferrin (600µg/ml) for indicated times, after which 
they were washed, harvested, and lysed. Lysates were then analyzed by Western blot for 
internal levels of labeled transferrin. Results show that transferrin recycling is delayed in PLD 
KO MEFs; characterized by a larger residual pool of transferrin in the KO MEFs per unit time. 
Statistical analysis was carried out using the Student’s t-test. *P < 0.05; Error bars represent 
















































Figure 29. Epidermal growth factor degradation in PLD WT/KO MEFs. 
Cells were starved overnight in serum-free media for 24 hours after which they were inoculated 
with starvation media containing 100ng/ml EGF for two hours. The media was subsequently 
swapped and incubated in serum-free media for the indicated time points after which cells were 
harvested and lysates were prepared and examined by Western blot. Statistical analysis was 






4 TABLES  
Table 1. The Arf family of G-proteins 
Human Gene 
symbol 
D. Melanogaster C.elegans S.cerevisiae Gene function/Reference 
Arf1 (Class1 Arf) CG8385 (Arf79F ) B0336.2 
(arf-1.2) 
Arf1/Arf2 Recruits COP1 coatomer, clathrin adaptor AP1 and GGA 
effectors to Golgi. 
 (D'Souza-Schorey and Chavrier, 2006; Nickel et al., 1998; Nie 
and Randazzo, 2006; Weiss and Nilsson, 2003). 
Arf3 (Class1 Arf)  B0336.2 
(arf-1.2) 
Arf1/Arf2 - 




 Partial overlapping functions with Class 1 Arf’s at the Golgi 
(Volpicelli-Daley et al., 2005). 





Arf6 (Class III 
Arf) 
CG8156 (Arf51F ) F45E4.1 
(arf-1.1) 
Arf3 Endocytosis, cytokinesis, cytoskeleton reorganization  
(D'Souza-Schorey and Chavrier, 2006). 
ARL1 CG6025 (Arf72A) F54C9.10 
(arl-1) 
Arl1 Membrane traffic at the Golgi apparatus (Munro, 2005). 
ArfRP1 (ARP1) CG7039 Y54E10B
R.2 
Arl3 Recruits Arl1 to trans-Golgi (Zahn et al., 2006). 
ARL2 CG7435 (Arf84F ) F22B5.1 
(evl-20) 
Cin4 Regulates microtubule dynamics (in C.elegans and 
Arabidopsis)  (Antoshechkin and Han, 2002) (Steinborn et al., 
2002) (Bhamidipati et al., 2000). 
ARL3 CG6560 F19H8.3 
(arl-3) 
 Regulates microtubule organization and transport in cilia ; has a 
role vesicle trafficking  (Ismail et al., 2011) (Schrick et al., 
2006). 
ARL4A (ARL4) CG2219   Recruits Arf6 GEFs (of the cytohesin family) to the plasma 
membrane (Hofmann et al., 2007). Modulates Golgi complex 
organization (Lin et al., 2011). 
ARL4C (ARL7) CG2219    
ARL4D  
(ARL4L, 5,6) 
CG2219   Function unknown; down-regulation is needed for adipogenesis 
to proceed (Yu et al., 2011a). 
ARL5A (ARL5) CG7197 ZK632.8 
(arl-5) 
 Function unclear. 
ARL5B (ARL8) CG7197 ZK632.8 
(arl-5) 
 Function unclear. 
ARL5C (ARL12)    Function unclear. 
ARL6 (BBS3) CG7735 C38D4.8 
(arl-6) 
 May contribute to flagellum biogenesis in trypanosomes (Price 










 Involved in spatial distribution on lysosomes (Bagshaw et al., 
2006; Hofmann and Munro, 2006). 
ARL9 /ARL10    Function unknown. 
ARL11 (ARLTS1)    May have tumor suppressor roles (Calin et al., 2005; Masojc et 
al., 2006). 
ARL13A CG17819 Y37E3.5   
ARL13B 
(ARL2L1) 
CG17819 Y37E3.5  May be involved in cilia architecture  (Caspary et al., 2007). 
ARL14    Involved in vesicular trafficking (Paul et al., 2011). 
ARL15    May be involved in glucose and fatty acid breakdown (Richards 
et al., 2009) 
ARL16 CG13692   Involved in immune responses (Yang et al., 2011). 
SAR1A 
(SARA1) 
CG7073 (sar1) ZK180.4  Involved in COPII vesicle formation (Lee et al., 2005; 
Matsuoka et al., 1998). 
SAR1B 
(SARA2) 
CG7073 (sar1) ZK180.4 Sar1 Involved in COPII vesicle formation  (Lee et al., 2005; 





Table 2. Arf GEFs 
GEF’s Arf Function 
ARNO 
[PSCD2] 
1-3,6 Actin remodeling, G-protein receptor desensitization, activation of calcium regulated exocytosis, 
regulation of dendritic branching, regulation of cell migration (Caumont et al., 2000; Chardin et al., 
1996; Claing et al., 2001; Frank et al., 1998a; Frank et al., 1998b; Gsandtner et al., 2005; Hurtado-
Lorenzo et al., 2006; Kitano et al., 2002; Mukherjee et al., 2000; Santy and Casanova, 2001; 
Venkateswarlu, 2003). 
 
ARNO 3 1 Involved in Golgi structure and function (Franco et al., 1998). 
 
Arf GEP100/Brag2 6 Involved in endocytosis, recycling  of β1 integrin (Dunphy et al., 2006; Someya et al., 2001). 
 
BIG1 1-3 Post-Golgi transport (Morinaga et al., 1996; Padilla et al., 2003; Saeki et al., 2005; Yamaji et al., 
2000; Zhao et al., 2002). 
 
BIG2 1-3 Involved in post-Golgi transport, and coat/adaptor recruitment (AP-1, GGA) (Li et al., 2003; Shin et 
al., 2004; Shinotsuka et al., 2002a; Shinotsuka et al., 2002b; Xu et al., 2005; Yamaji et al., 2000). 
 
Cytohesin-1 [PSCD1] 1 Required in the regulation of β2 integrin adhesion, synaptic transmission  (Ashery et al., 1999; 
Kolanus et al., 1996; Mansour et al., 2002; Pacheco-Rodriguez et al., 1998; Schurmann et al., 1999; 
Vitale et al., 2000). 
 
Cytohesin 2 /ARNO 1, 6 Required for β-1 integrin recycling, remodeling of actin cytoskeleton, regulation of cell migration 
and membrane ruffling (Bouschet et al., 2007; Li et al., 2007a; Oh and Santy, 2010; Santy and 
Casanova, 2001). 
 
Cytohesin-4 [PSCD4] 1,5 Function not determined (Ogasawara et al., 2000). 
 
EFA6 Exchange 
Factor for Arf6) 
6 Induces migration and invasion in glioma 
Overexpression induces membrane ruffles, neurite extension 
Binds, F-actin and PI(4,5)P2 simultaneously (in vitro). PI(4,5)P2 binding is via a PH domain  (Li et 
al., 2009; Macia et al., 2008; Sironi et al., 2009). 
 
EFA6 [PSD] 6 Actin remodeling, endocytosis, recycling (Decressac et al., 2004; Franco et al., 1999; Macia et al., 
2001). 
 
EFA6A 6 Maintenance of dendritic spines (Choi et al., 2006a; Sakagami, 2008; Sakagami et al., 2007; 
Sakagami et al., 2004; Sakagami et al., 2006). 
 
EFA6C 6 Regulate membrane dynamics in Purkinje cells (Matsuya et al., 2005; Sakagami, 2008). 
 
EFA6D 6 May regulate post-synaptic vesicle trafficking (Sakagami, 2008; Sakagami et al., 2006). 
 
GBF1 1-3,5 ER and Golgi transport and COP1 recruitment (Claude et al., 1999; Garcia-Mata and Sztul, 2003; 









1,6 β1-integrin endocytosis, Growth-factor signaling (NGF, EGF, Insulin) (Franco et al., 1998; 
Klarlund et al., 2001; Langille et al., 1999; Nevrivy et al., 2000; Oh and Santy, 2010; Poirier et al., 
2005). 
msec7-1 Arf ND: High expression in the brain and adrenal (Telemenakis et al., 1997). 









Table 3. Arf GAPs 
GAP Regulates (Arf) Comment  
ACAP1 6 Part of a clathrin coat complex that functions in stimulation dependent recycling of  
integrins during cell migration (Li et al., 2007b). 
 
ASAP1 Arf Associaes with focal adhesions, circular dorsal ruffles  




1,5,6 Stimulated by PI(4,5)P2, associates with focal adhesion and circular dorsal ruffles, positive 
regulator of stress fibers and hepatocellular migration (Ha et al., 2008). 
 
Associates with focal adhesions, circular dorsal ruffles. Induces formation of actin stress 
fibers. 
 
Cantaurin-alpha1 6 Mediates vesicular trafficking by interacting with the motor protein KIF13B 
(Kanamarlapudi, 2005). 
 
GIT-1  6 Forms Arf6 mediated, agonist promoted complex with FAK to regulate focal adhesion 
turnover 
G-protein coupled receptor endocytosis (Daher et al., 2008). 
 
GIT-2  G-protein coupled receptor endocytosis (Hoefen and Berk, 2006) 
 
IQGAP1  6 Knockdown inhibits Arf6 induced RAC1 activation and cell migration (Hu et al., 2009). 
 
Smap1  6 Interacts with clathrin, functions in E-cadherin endocytosis, Overexpression impedes E-
cadherin traffic and reduces migration (Kon et al., 2008). 
 



















Table 4. Arf6 regulated events 
 
Migration and Invasion 
Disassembly of adherens junctions and E-cadherin recycling (D'Souza-Schorey, 2005; Hiroi et al., 2006; Palacios et al., 2001; Palacios et 
al., 2002; Palacios et al., 2005) 
 
Receptor internalization and growth signaling (Tushir et al., 2010) 
 
β1 integrin trafficking and migration (Crowley et al., 2009; Li et al., 2005; Oh and Santy, 2010; Pellinen and Ivaska, 2006; Powelka et al., 
2004; Yu et al., 2011b) 
 
Actin cytoskeletal remodeling, migration and cell invasion  (Balasubramanian et al., 2007; D'Souza-Schorey and Chavrier, 2006; Jones et 
al., 2009; Li et al., 2006; Nishiya et al., 2005) 
 
Invadopodia formation (Brooks et al., 1996; Deryugina et al., 2001; Hashimoto et al., 2004; Mueller et al., 1999; Nakahara et al., 1998; 
Tague et al., 2004) 
 
Protease-loaded micro vesicle release (Muralidharan-Chari et al., 2009a; Muralidharan-Chari et al., 2009b) 
 
Epithelial cell scattering and cell invasion (Palacios and D'Souza-Schorey, 2003; Sabe, 2003) 
 





Cleavage furrow formation and membrane addition during cytokinesis (Dyer et al., 2007; Fielding et al., 2005; Wilson et al., 2005) 
 
Abscission (Montagnac et al., 2009; Schweitzer and D'Souza-Schorey, 2002, 2005) 
 
Coordination of vesicle traffic  with the exocyst complex (Chen et al., 2006; Gromley et al., 2005; Prigent et al., 2003) 
 
Membrane trafficking  during cytokinesis (Chesneau et al., 2012; Montagnac et al., 2009; Schweitzer and D'Souza-Schorey, 2005; 
Takahashi et al., 2011) 
 
Cholesterol/Lipid homeostasis homeostasis  
 
Cholesterol uptake/efflux (Naslavsky et al., 2004) 
 




Arf6 dependent membrane trafficking (Balasubramanian et al., 2007; D'Souza-Schorey and Chavrier, 2006; Donaldson, 2005) 
Clathrin independent endocytosis (Donaldson et al., 2009; Tanabe et al., 2005) 
Endocytic recycling (Li et al., 2007b; Schweitzer et al., 2011) 
Macropinocytosis (Radhakrishna et al., 1996; Svensson et al., 2008) 
 
Cytoskeletal (actin) Rearrangements 
 
Actin remodeling (Li et al., 2007a; Macia et al., 2008; Radhakrishna et al., 1996; Rescher et al., 2004; Venkateswarlu et al., 2007; Welch et 
al., 2005) 















No. of litters 
No. of mice with genotype  
% of Arf6-/- mice Arf6+/+ Arf6+/+ Arf6+/+ 
E11.5 20 46 82 40 23.8 
E13.5 17 38 64 25 19.7 
E15.5 6 11 21 5 13.5 
E18.5 12 27 39 7 9.6 
P0.5 8 12 25 1 2.6 
P21  203 376 1 0.2 
aP, postnatal day.  



















Table 6. Distinguishing characteristics of PLD isoforms 
 PLD1 PLD2 
PIP2-dependent + + 
RalA-associated + - 
Activated by:    
 Arf-family GTPases + ? 
 Rho-family GTPases + - 
 PKC-α + ? 
 Fatty Acids - + 
Molecular weight 120,000 96,000 
Present in autophagosomes + - 
Predominant cellular location Peri-nuclear, Golgi Plasma membrane, rafts 











5.1 Plasmids and Reagents  
 
Sources of cDNAs were as follows: Arf6-eGFP (Julie Donaldson), Vps29-yfp (Scott Smalls), 
Fyve-eGFP (Gilbert Di Paolo).  
Other reagents were obtained from the following sources: Fibonectin (Sigma F2006), Biotin 
labeled-Colera Toxin B Subunit  (Sigma c9972), Tamoxifen (Sigma H7904), Transferrin-Holo 
form (Gibco 11107018), Transferrin Biotin-XX (Invitrogen T23363), Deferoxamine mesylate 
salt (sigma D9533), Trypsin Inhibitor for Glycine max (Sigma T6414), Lopofectamine® LTX 
and Plus Reagent (Invitrogen ),  
Tublin (Sigma T5168)), Arf6 antibodies were a kind gift from Julie Donaldson, Clathrin (BD 
Transduction Laboratories 610500), FAK (Santa Cruz sc558), Rab5 (Synaptic Systems 108011), 
Annexin (BD-Transduction Laboratories 610068), vps35 (abcam 10099), gm130 (BD-
Transduction Laboratories 610823), Rab11 (Zymed 71-5300), Flotillin (BD-Transduction 
Laboratories), Rab7 (abcam ab50533), Transferrin receptor (Invitrogen 136800), EGFR (Upstate 
cell signaling solutions rb06847ab48), Transferrin-Alexa488 (Invitrogen T13342), Cholera toxin 
subunit b-Alexa 555 (Invitrogen c34776).  
Secondary antibodies are as follows: Streptavidin hrp conjugate (Invitrogen s011), Goat-
anti-Rabbit-HRP conjugate (Biorad 1706515), Goat-anti-Mouse-HRP conjugate (Biorad 







5.2 Generation of Arf6 KO mice  
 
To generate Arf6 conditional KO mice, the entire coding sequence (~400bp) was flanked with 
loxP sites,  with one (loxP) sub-cloned into a targeting vector upstream of the Arf6 coding region 
at an SspI site and a FRT-NEO-FRT-loxP cassette inserted downstream of the Arf6 sequence. 
The targeting vector was electroporated into ES cells and successfully-targeted ES cells were 
microinjected into blastocysts, which were then transferred into foster mothers for the generation 
of chimeric mice. Resultant Arf6Floxed-Neo/+ mice were crossed with a Rosa Flp Deleter mice 
to generate Arf6-Floxed/+ mice (Fig. 5, see “FLP deletor”). These mice were then crossed with 
the inducible Cre-ER mice (Rosa B6 Cre-ER/Cre-ER), to generate Arf6-Floxed/+, Cre-ER mice, 
which were then interbred to generate Arf6-Floxed/Floxed,Cre-ER mice.   
 
5.3 Generating Arf6 MEFs  
 
To generate immortalized MEFs, torsos from Arf6-Floxed/Floxed, Cre-ER MEFs were minced 
and trypsinized for 15min and homogenized by pipetting. Cells were then centrifuged, re-
suspended and cultured in normal growth media (DMEMglutamax-Invitrogen, 10% FBS+P/S). 
Cells were passaged every 3-4 days and became immortalized at about passage 25. KO MEFs 
were derived from this immortalized parental line by induction with tamoxifen (sigma). Here, 
cells were plated at low density (350cells/mm
2
) in the presence of 10uM tamoxifen or vehicle 
(0.1% DMSO) for three days, after which they were passaged for three more days in the absence 
of drug. Gene deletion occurred over a period over one week (see Fig. 6) and WT and KO lines 






5.4 Generation of PLD2 KO mice/MEFs 
 
The HKD motif (denoting HxKxxxxD/E) is a highly conserved domain in the PLD family and 
point mutagenesis of these amino acids has revealed that they are critical for catalysis. There are 
two HKD motifs in PLD1 and PLD2 and these motifs interact with each other to form the 
catalytic site. Exon 14 of the PLD2 gene contains the first HKD motif. To generate PLD2 KO 
mice, exon 13,14 and 15 were deleted using the Cre-loxP strategy, where a  LoxP sequence was 
sub-cloned into a targeting vector at an MfeI site upstream of exon 13 whilst an FRT-Neo-FRT-
LoxP cassette was inserted at an SspI site downstream of exon 15 (see Fig. 24a).   
The targeting vector was electroporated into ES cells (129vEvTac) and after positive and 
negative selection, successfully-targeted ES cells were microinjected into blastocysts (C57BL/6). 
Resulting embryos were transferred into foster mothers for the generation of chimeric mice. 
Germ-line transmission was confirmed by crossing chimeric mice with C57Bl/6J mice and 
assaying for the presence of Pld2Floxed-neo/+ mice in the F1 offspring. 
Pld2–/– mice were produced by crossing Pld2Floxed-neo/+ mice with a deleter strain Cre 
recombinase mice (Rosa26 Cre/Cre, Jackson Lab), to eliminate exons 13-15 producing Pld2+/– 
mice.  Pld2+/– mice were then intercrossed to create Pld2+/+ and Pld2–/– mice. The genetic 
background of the animals is mixed (C57Bl6, 129SVJ). Southern blot analysis of genomic DNA 
that was extracted from the tail of mice derived from Pld2+/– mouse intercrosses (Oliveira et al., 
2010): DNA was digested with PstI and hybridized with a [32P] labeled-probe located to the 5' 
region (outside the targeting vector) of the targeted genomic region. The autoradiogram shows 
the wild type (+/+), knockout (–/–) and heterozygous (+/–) genotypes. The sizes of the wild-type 






WT and KO MEFs were both generated in parallel (non-inducible) from mice embryos (see 
protocol described for Arf6)  
 
5.5 Western Blot 
 
Cells were lysed in lysis buffer [150mM NaCl2, NP40 (roche 11332473001) 40mM Tris-HCL 
pH 7.5, 1mM Na3VO4,10mM NaF, Protease  Inhibitor (Roche # 11836179001) )] and extracts 
were centrifuged at 13,000rpm, for 5min at 4
0
C. Protein concentration was measured using 
Coomassie Plus Protein Assay Reagent (Pierrce) and prepared in SDS loading sample (NuPage® 
system, Invitrogen). Equal amounts of proteins were loaded and separated by SDS-PAGE and 
transferred unto nitrocellulose membrane using the iBlot®7-Minute transfer system. Membranes 
were then probed with indicated primary and secondary antibodies coupled with HRP for ECL 
detection using a Fuji LAS4000 Imaging unit (GE Healthcare). Bands were quantified and 
analyzed using ImageJ software (NIH).  
 
5.6 Transferrin Uptake 
 
For transferrin uptake assays, cells were stared for 1hour in serum free media (DMEM+0.1% 
BSA; note that this treatment frees surface receptors form ligands) followed by incubation with 
transferrin-biotin (20ug/ml)-in serum free media, at 37
0
C for indicated times. At the desired time 
point cells were quickly chilled and washed with ice-cold 1xPBS followed by a cold acid wash 





transferrin, after which they were lysed and prepared for Western Blot (see above). Membranes 
were then probed with streptavidin (see reagents above) and imaged (see Western blot above).    
For immunofluorescent transferrin uptake assays, cells grown on coverslips were pulsed with 
Transferrin-Alexa488 (rather than transferrin-bioin) and at the desired uptake time point, were 
washed with ice-cold PBS, acid stripped, washed again, and fixed with 4% PFA (diluted in 
1xPBS) for 20min and washed. Coverslips were then mounted and processed for 
immunofluorescent staining.   
 
5.7 Transferrin Recycle 
 
For transferrin recycling assays, cells were starved for 1hr in serum-free media (DMEM+0.1% 
BSA) after which they were incubated for an additional hour with transferrin-biotin (in serum-
free media) to fully label the endosomal receptor pool. Cells were quickly chilled, by a cold wash 
with 1xPBS followed, by a brief acid wash (~3min) to remove the cell surface bound transferrin. 
Cells were then subsequently washed again with 1xPBS and incubated at 37
0
C in starvation 
media supplemented with excess unlabeled transferrin (600ug/ml Holo-transferrin) supplemented 
with 200ug/ml deferoxamine.  Transferrin recycling (measured as the loss of biotin-labeled 
transferrin from cells) was arrested at different time points, by washing and lysing cells. Extracts 
were then prepared for Western as described above.  
 






In the EGF degradation assays, cells were starved for 18 hrs in serum-free media to induce the 
expression of the EGFR at the cell surface. Cells were then inoculated with 100ng/ml of EGF (in 
starvation media) for indicated time points. Cells were then lysed and extracts processed for 
western blot (see western procedure above). Membranes were then blotted for EGFR levels and 
blots were then imaged and quantified as described above.  
 
5.9 Cell spreading assay 
  
Cells were detached by trypsinization and neutralized with an equal volume of trypsin inhibitor 
(see materials above). Cells were then centrifuged washed (in PBS) and re-suspended in  Ringers 
buffer (150mM NaCl2, 5mM KCl, 1mM MgCl2, 20mM HEPES, 2g/L glucose (pH7.4)) for 
30min under growth conditions (37
0
C x 5% CO2). Coverslips were previously coated with 
10ug/ml FN overnight, washed 3x with PBS, followed by a 30min incubation with 1% BSA (in 
PBS). These were subsequently washed with PBS and incubated at 37
0
C in the Ringers buffer. 
Cells were then inoculated unto coverslips (120cells/mm
2
) and allowed to spread for different 
time points, after which they were fixed with PFA.  
 
5.10 Cell size quantification  
 
To measure cell-size, fixed coverslips were submerged for 30min in a solution containing PBS 
and Alexa-coupled Wheat Germ agglutinin (WGA), which labels the cell surface area. Coveslips 
were then rinsed and directly imaged (no mounting) on a live imaging chamber (see 





In image-j, picture images were split into component channels (using the following path: 
Image/color/split channels),  and the WGA labeled channel was thresholded  
(image/adjust/threshold) and sliders were adjusted to demarcate the cell perimeter (note this was 
guided by corresponding DIC images). Cell area was then measured using the wand (tracing 
tool). For each experimental condition, ~1300 cells (total) were quantified from three 
independent experiments. Results were tabulated using the frequency function in Microsoft 
Excel.   
5.11 Microscopy 
 
For image acquisitions of spread cells, fixed coverslips were placed in a Chamlide recording 
chamber (Life Cell Instruments, South Korea) filled with 300ul of Ringers buffer, and images 
were acquired using an Olympus IX-81 microscope connected to a Hamamatsu CCD camera 
(Hamamatsu Photonics) mounted with a 10x objective (Olympus). Images were collected using 
Slidebook 5.0 software (Olympus).  
For live imaging, cells were very sparsely plated (~5cells/mm
2
) unto a glass bottom 35mm dish 
(Mat Tek Corporation p35g-1.5-14-c) and allowed to spread completely on a heated, CO2 -
equipped incubator (MIU-IBC-IF), using a 60x objective. Spread cells were then used to 
determine an optimal focal plane for imaging spreading cells, which were in turn inoculated 
directly into the live imaging chamber for movie recording.  
For fixed acquisitions, mounted and stained coverslips were, imaged using a Nikon EZ-C1.2.30 
confocal microscope and an oil-immersion objective (60x). To determine co-localization 
percentages, (i.e. for transferrin, uptake assays) overlapping pixels between red and green 





localizations was determined using the following equation: % colocalization = 100x overlapping 
pixels/total red (or green) positive pixels.  
5.12 Immunofluorescence  
 
Fixed coverslips were blocked for 30min with antibody diluent (5% BSA (in 1xPBS), 0.1% 
TritonX-100, for 30min, followed by 30min of incubation with primary antibody. Coverslips 
were then washed 3x with 1xPBS (3min each) followed by 30min with secondary antibody. 
Finally coverslips were washed again 3x with 1xPBS (3min) followed by 2x with water (10min), 
before being mounted in Vectashield with DAPI (Vector).  
5.13 Lipid analysis  
 
Lipid changes during cell spreading was monitored using HPLC. Our lab has set up a mass assay 
for the analysis of anionic phospholipids based on the separation of lipid extracts by anion 
exchange (HPLC). Briefly, dishes are scraped in ice-cold MeoH:1M HCL (1:1) supplemented 
with 2mM AlCl3. Lipids are extracted and deacylated in a 40% methylamine reagent and 
incubated at 50°C for 45min and the aqueous phase is dried and re-suspended in a solvent 
solution (n-butanol: petroleum ether:ethyl formate (20:40:1). Following subsequent extraction 
with water, lipids are finally subjected to anion-exchange HPLC column. Negatively charged 
glycerol head groups are eluted with a 1.5-86 mM KOH gradient and detected online by 
suppressed conductivity in a Dionex Ion Chromatography system equipped with an ASRS-ultra 
II self-regenerating suppressor. Individual peaks are identified and peak areas are calculated 





lipid masses are calculated and expressed in molar fractions of total anionic. phospholipids 




Statistical analysis was performed using two-tailed equal variance and Student’s t test, unless 
indicated otherwise in the Figure legends. P-values < 0.05, < 0.01 and <0.001 were determined 
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